سرپرست دانشگاه جهانی کورش بزرگ

Massoud Mirshahi

Titres et travaux scientifiques

  • M. Mirshahi, M. D., Ph. D.

  • Université de Paris

  • CAP- Paris Tech., INSERM U1275

  • Carcinose Péritoine Paris Technologie

  • Hôpital Lariboisière

  • 2, rue Ambroise-Paré

  • 75010, Paris, France

  • Tel: 00 33 664373220

  • Fax: 00 33 1 53216739

  • mail: massoud.mirshahi@inserm.fr

Google Scholar Profile

Massoud MIRSHAHI: M. D., Ph.D, French nationality, Researcher in CNRS (1986- p), Professor of oncology (2009-p), Academician (2002) (FM), Co-head of Regenerative Medicine in Avicenna University, Dushanbe (Tajikistan 2009-p), Several patents and licenses for industrial exploitation, several scientist awards such as Immunopathology of the Eye, Tokyo Japan, 1986, American College of Toxicology » 2002, Pennsylvania, USA, Prize of “Institut de France” (Prix Dalloz), 2006, Paris, south Korea cancer institute 2017, over 200 international scientific publications, 290 congress communications. Editor en chef for several scientific journal, Reviewer in several International Journals such as in Oncology, immunology and Ophthalmology fields. Member of several International Academic Associations, Thesis director of more than 20 thesis, as well as several postgraduate students, Masters, and postdoctoral students. Obtaining of research grants from several local associations, French or foreign industries and foundations. Main research specialty is: cancerology, immunology, fibrinolysis, thrombosis and coagulation, ocular immunopathology, principal activity: role of the microenvironment in cancer cell proliferation, metastasis and resistance to therapy. Discovery of a tumor micro-environmental cell (named Hospicell) protecting cancer cells from chemotherapy by different mechanisms. Stem cell therapy for heart regenerative medicine and target therapy in cancer disease.


Key words: Arrestin, Plasminogen Activators, Fibrin-Fibrinogen, Thrombosis, D-Dimer, Autoimmune-Disease, Mineralocorticoid Receptor (MCR), Epithelial Sodium Channel (Enac), Ophthalmology (Retina And Cornea), Cancer, Angiogenesis, Chemoresistance, Leukemia, Bone Marrow Stromal Cells, Hospicell, Biomaterial, Nanoparticle, Radio-Frequency Plasma, Mesenchymal Cells, Stem Cells, Regenerative Medicine, Carcinomatosis. Personalized Medecine. Cancer and Thrombosis, Immunology of Cancer, HLA-G.


CURRICULUM VITAE

Massoud MIRSHAHI

Né le 19 Mai 1954 à Nishabour (Iran)

Nationalité : Française, marié, deux enfants

Titres : Docteur, Professeur, Academicien

Diplôme :

- DERBH en Physiologie et Biochimie de l'hémostase

(Pr. Caen -Faculté de Médecine de Paris VII), 1987.

- Doctorat d'Etat en Science de Biologie Humaine [immunologie]

(Pr. Seligman Faculté de Médecine de Paris VII), 1986

- Doctorat en Médecine.

(Pr Hemker, Université de Limbourg, Holland), 1984

- AEA de Physiologie et Biochimie de l'hémostase

(Pr. Caen Faculté de Médecine de Paris VII), 1984

- AEA d'Immunogénétique et Transplantation, Immunopathologie

(Pr. Seligeman Faculté de Médecine de Paris VII),1984

- Certificat d'Etudes Supérieures d'Immunologie Générale

(Pr. Homberg -Faculté de Médecine de Paris VI), 1983

- Certificat d'Etudes Supérieures en Cancérologie Générale et expérimentale

(Pr. Mathé-Faculté de Médecine de Paris XI), 1983

Activités :

  • Directeur de departement innovation pharmaceutique et la médecine experilental, Tajikistan National Academie of Science, 2018.

  • Directeur d’un groupe de recherche sur Carcinose Péritoine INSER U965 (2015-2019) et l’INSERM U1275 (2019 -…)

  • Directeur d’un groupe de recherche sur « Rôle du micro-environnement médullaire dans la survie des cellules cancéreuses » CRC, UMRS872 (1999-2015),

  • Directeur d’equipe de reherche (physiologie et immunopathologie oculaire), INSERM U86, XU86, 1986-1998.

  • Professeur en Cancérologie, Faculté de Médecine d’Avicenne, Tadjikistan, 2009.

  • Membre et Professeur à l’Académie des Sciences du Tadjikistan, 2002

  • Directeur d’un groupe de recherche sur physio pathologie de l’œil, INSERM U86.

  • Chargé de recherche au CNRS (1ère classe), France 1986, CRHC, 2018.

  • Médecin Attaché aux hôpitaux de Paris (1988-1998)


Autres activités :

  • Membre de Conseil de Gestion, Faculté de Médecine, Paris VI (1998-2001)

  • Membre de Conseil de Gestion, Institut Biomédicale des cordeliers (2003- 2006)

  • Membre d’AERES, 2008

Membre des sociétés scientifiques :


  • International Society of Precision Cancer Medicine, Corée du sud

  • American Chemical Society, USA

  • Endocrine Society, USA

  • Groupe de Réflexion sur la Recherche Cardiovasculaire, France

  • Académies des Sciences (Tadjikistan)

  • New York Academy of Sciences, USA

  • Association for Eye Research, Europe

  • Société des Neurosciences, France

  • Société Française d'Immunologie, France

  • International Society for Fibrinolysis and Thrombolysis, Europe

  • Association for Research in Vision and Ophtalmology, USA


Bourse et Prix Scientifiques :


  • Bourse de la Fondation pour la Recherche Médicale, 1983-84

  • Prix de la Fondation de France-IPSEN, 1986, Paris-France

  • Prix d’Immun pathologie oculaire 1990, Tokyo, Japon

  • Prix de « American College of Toxicology » 2002, Pennsylvania, USA

  • Prix de l’Institut de France (Prix Dalloz), 2006, Paris, France

  • Prix de l’institur de Cacerologie, Séoul, Corée, 2016.


Subventions et contrats divers :


  • Rétina France,

  • ARC,

  • Fondation de France,

  • Servier, France

  • Fondation des gueules Cassées,

  • Baxter. Germany (2005-2011),

  • Stago Diagnostica, France (2008-2010)

  • ARCAGY, France, (2010-2012)

  • Qatar Founation (2010-2014)

  • INCA, institut national contre cancer (2014-2017)

Direction et contribution à des thèses et mémoires

de Maîtrise et DEA, Master 1 et 2

Thèse :


  1. 1995 Lopez Alemany Roser. Purification et caracterisation biochimique du récepteur de la plasmine et du plasminogène dans des cellules carcinomateuses humaines.

Thèse de Doctorat en Sciences, Paris XI

  1. 1998 Nicolas Corine. Les protéines apparentées à l’arrestine visuelle, expression et immuno localisation dans les tissus oculaires.

Thèse de Doctorat en Sciences, Paris VI

  1. 2000 Merodio de la Quintana Marta. Albumin nanoparticules form for the administration of gancilovir,

Thèse de Doctorat en Sciences, Université de Navarra, Espagne (Co-Direction).

  1. 2000 Golestaneh Nady. Les récepteurs minéralocorticoides et les canaux à Na des tissus épithéliaux (ENaC), expression, régulation et immunolocalisation dans les tissus oculaires et les cellules non épithéliales.

Thèse de Doctorat en Sciences, Paris VI.

  1. 2002 Ghedira Ibtissem. Anticorps monoclonaux contre l’arrestine et la transducine de la rétine

Thèse de Doctorat en Sciences, Université de Monastir, Tunisie

  1. 2003 Vincent Loïc. Le stroma dans les maladies vasculaires et malignes: Physiopathologie de l’angiogenèse et développement de nouvelles stratégies anti- angiogéniques. Physiopathologie des cellles stromales issues des cellules souches dans les leucémies.

Thèse de Doctorat en Sciences, Université de Rouen. (Co-direction)

  1. 2008 Rafii Arash. Rôle du micro environnement des adénocarcinomes ovariens et mammaires sur l’implantation et la survie des cellules tumorales ; mécanismes cellulaire et moléculaire.

Thèse de Doctorat en Sciences, Paris XI

  1. 2009 Ducros Elodie. Cancer et thrombose, le rôle du récepteur de la protéine C.

Thèse de Doctorat en Sciences, Paris XI

  1. 2010 Sakly Nabil. Implication des anticorps anti cellules endothéliales et des anticorps anti nucléaires dans l’angiogenese au cours du lupus erythémateux systemique.

Thèse de Doctorat en Sciences, Université de Monastir, Tunisie (Codirection).

  1. 2010 ZAHIR Muraf. La protéine 'BH3-Only' Noxa, cible spécifique de l'induction d'apoptose pour la thérapie des leucémies lymphoïdes chroniques. (Codirection)

Thèse de Doctorat en Sciences, Paris XI (16 septembre 2011)

  1. 2011 Lis Raphaël. Rôle du microenvironnement dans la survenue de la maladie métastatique et l’apparition d’une maladie résiduelle.

Thèse de Doctorat en Sciences, Paris XI (18 novembre 2011)

  1. 2012 Touboul Cyril. Influence du stroma et des cellules souches mésenchymateuses sur la dissémination et la résistance au traitement des carcinomes ovariens épithéliaux Thèse de Doctorat en Sciences, Paris XI (21 novembre 2012)

  2. 2012 Azzazene Dalel. Cancer de l’ovaire et immunité anti tumorale, rôle de l’« human leukocyte antigen»(HLAG),

Thèse de Doctorat en Sciences, Paris XI (06 décembre 2012)

  1. 2012 Benabbou Nadia. Implication de « l’insulinlikegrowth factor -1 » (IGF-1) secrété par le microenvironnement tumoral, dans la survie et la chimiorésistance des cellules cancéreuses.

Thèse de Doctorat en Sciences, Paris XI (21 décembre 2012)

  1. 2015 Besbes Samaher: Rôle de la Protéine C, un anticoagulant naturel, dans l’association thrombose et cancer.

Thèse de Doctorat, (ecole doctoral de Cancerologie, Paris Sud), Septembre 2015, (Co Direction avec Univesité de Monastir, Tunisie)

  1. 2015 Al Farsi Halema: In Silico Mutagenesis Approach To Define Molecular Targets In Ovarian Cancer.

Thèse de Doctorat, (ecole doctoral de Cancerologie, Paris-saclay), Novembre 2015, (Co Direction avec Branche de l’Université de Cornell, New york, Doha-Qatar).

  1. 2015 Al Thawadi Hamda: Microparticles Mediated Cross-talk between Ovarian Cancer and Endothelial Cells.

Thèse de Doctorat,(ecole doctoral de Cancerologie,Paris -Saclay), Novembre 2015, (Co Direction avec Branche de l’Université de Cornell, New york, Doha-Qatar).

  1. 2017 Shahid Shah, Identification of future target therapy in peritoneal carcinomatosis, the role of Fibrin and Heparanase, Thèse de Doctorat, (ecole doctoral de Hematologie, Oncogenèses et Biothérapies), Dcembre 2017,

  2. 2019 Matti Ullah, Immune Check point in carcinomatosis, the role og HLA-G. Thèse de Doctorat,(Ecole doctoral de Cancerologie,Paris -Saclay), 19 Septembre 2019,

D’autres theses :


  1. 1991 Tarraf Mohamed. Greffe d’ébauche de l’œil chez les pleurodèles, différenciation des photorécepteurs et survie de l’œil greffe

Thèse de l’Ecole pratique des hautes études, Paris, (Codirection)

  1. 1992 Razaghi Ahmed, Les protéines apparentées à l’antigène –S , arrestine : une nouvelle famille de protéines.

Thèse de Doctorat en Sciences, Paris VI, (Codirection)

  1. 1994 Lebrazi Jamal. Aspect biologiques du traitement par la streptokinase.

Thèse de Doctorat en Sciences, Paris VI, (Codirection)

  1. 1996 Lehmann Faru Carina. U-PA récepteur dans les fibroblastes de la cornée,

Thèse de doctorat, faculté de Médecine, Berlin, Allemagne,

  1. 2001 Wemming Chen. Régulation physiopathologique de l’angiogenèse et son contrôle en thérapeutique, application au myélome. Nouvelles stratégies d’inhibition de l’angiogenèse.

Diplôme d’Etudes Doctorales, Université de Rouen. (Codirection).

DEA et Master-2


  1. 1989 Jean Christoph Zech. Anticorps, monoclonaux contre des produits de dégradation de l’antigène -S, arrestine.

DEA Différentiation, Génétiques et immunologie, Lyon.

  1. 1991 Devillers Céline. Etude de l’interaction rhodopsine –arrestine.

DEA Structure et fonction des systèmes biologiques intégrés, Paris XI

  1. 1994 Tchtinsky Gabrielle. Les protéines apparentées à l’arrestine dans l’embryogenèse chez les plantes supérieures.

DEA Biologie moléculaire et cellulaire végétale, Paris XI.

  1. 2005 Simon Anne. Etude des protéines impliquées dans les phénomènes de résistance multiples aux chimiothérapies dans le microenvironnement cellulaire tumoral

Master-2, Biologie cellulaire et moléculaire, Paris VI

  1. 2005 Ducros Elodie. Rôle de SDF-1 secrété par les cellules stromales de la moelle osseuse sur la migration des cellules cancéreuses, rôle de la GTPase Rho.

Master-2, Cancérologie, Paris XI

  1. 2007 Benabbou Nadia. Induction du MDR sur les cellules leucémiques par l’IGF-1 (insuline growth factor-1).

Master 2, Biologie Moléculaire et Biochimie, Paris VI.

  1. 2008 Azazzone Dalel. Recherche de l’HLA-G dans certaines cellules stromales du microenvironnement tumoral.

Master 2, Biologie Intégrale, Versailles.

  1. 2008 Bermont Cécile. Cancer et thrombophilie : rôle du récepteur de la proteine C.

Master 2, Santé Mention Biologie Cellulaire, Paris V

  1. 2008 Zahir Muraf. Recherche d’effets pro-apoptotiques d’un extrait naturel M2Yn sur les cellules de la leucémie lymphoïde chronique B.

Master 2, Pharmacologie et thérapie anti tumorale, Paris XI.

  1. 2010 Martin Laurène : Interaction des cellules souches tumorales ovariennes avec leur microenvironnement.

Master 2, Université paris V.

  1. 2012 Geyl caroline : Etude de l’influence des cellules souches mésenchymateuses dans la chimiorésistance liée à des anomalies de réparation de l’ADN dans le cancer de l’ovaire à un stade avancé.

Master 2, Université Paris VI.

  1. 2013 Sharif Camélia, Etude de différentes fractions provenant d’un extrait naturel M2Yn, sur la prolifération et la migration en temps réel de cellules cancéreuses.

Master 2, Université Paris V.

  1. 2015 Helfer Hélène : Rôle du VEGFR-1/VEGF dans le défaut de cicatrisation lors d’une thérapie antiangiogénique. Master-2 Recherche Science du médicament Spécialité Pharmacologie intégrée pré-clinique et clinique (université paris Descartes).

  2. 2015 Jamshidov Jovid: Rôle Du TNF-α dans le Détachement d’un caillot de fibrine fixé sur les cellules endothéliales. Intérêt dans la physiopathologie des embolies.

Master-2, Mention Sciences Biomédicales, Spécialité Physiologie (Université de Rouen)

  1. 2015 Fourgeaud Caroline : Héparanase dans l’induction de l’activité pro coagulante chez les malades atteints de cancer. Master-2 Thérapeutique, Evaluation et Optimisation (université paris Descartes).

  2. 2015 Attal Raphaël : Le rôle des microparticules dans le cancer de l’ovaire et son implication dans la thrombose et la progression tumorale. Master-2 Biologie Cellulaire Physiologie et Physiopathologie, Spécialité « BiVATH », (Universités Paris Descartes et Paris Diderot).

  3. 2015 Gosset Pietrasz Marie : Evaluation d’une thérapie ciblée anti-IL6 sur la progression tumorale et la chimiorésistance dans un modèle murin de carcinose ovarienne.

Master-2 sciences chirurgicales, parcours cancérologie. (Université Paris-Est, Créteil Val de Marne)

  1. 2015 Miailhe Grégoire : Etude de la potentialisation de la chimio ‐hyperthermie intra-péritonéale sur un modelé murin de carcinose péritonéale ovarienne. Master-2 sciences chirurgicales, parcours cancérologie. (Université paris Sud).

  2. 2016 Audrey CHEVROT : Impact du microenvironnement et d’une thérapie ciblée anti-IL6-R sur la carcinose péritonéale d’origine ovarienne au cours d’une chimiothérapie conventionnelle,

Master-2 Sciences Chirurgicales option cancérologie 2015-2016, (Université Paris XI).

  1. 2016 Alexandra ARFI: impact du microenvironnement et d'une thérapie ciblée anti-cxcr4 sur la carcinose péritonéale d'origine ovarienne au cours d'une chimiothérapie hyperthermique intrapéritonéale, Master -2 de sciences chirurgicales parcours cancérologie, (Université Paris-Est, Créteil Val de Marne

  2. 2017 Morgane Blot Dupin,

Master -2 de sciences chirurgicales parcours cancérologie, (Université Paris-Est, Créteil Val de Marne)

  1. 2017 Arnoud Bresset,

Master -2 de sciences chirurgicales parcours cancérologie, (Université Paris-Est, Créteil Val de Marne).

  1. 2018 Djedjiga Abdelhamid La régulation des proteases à sérine par la thrombine dans la cavité péritoeal.

Master-2, Recherche phalmacologie intégrée préclinique et clinique, Université Paris Descartes.

  1. 2018 Sarah Meziani Influence des inducteurs de la differenciation sur l’expressio d’HLA-G et de PDL-1 dans les cellules souches de cancer

Master-2, Recherche phalmacologie intégrée préclinique et clinique, Université Paris Descartes.

  1. 2019 Meriam Belalou, Étude de l’interaction des cellules cancéreuses avec la fibrine générée sur la paroi péritonéale et de l’impact de l’icodextrine sur cette adhérence, Université Cergy pontoise

  2. 2019 Warda Aoudjeghout, Contrôle du système immunitaire dans la carcinose digestive / Impact de l’HLA-G, PDL-1 et CTLA-4., Master-2, Recherche phalmacologie intégrée préclinique et clinique, Université Paris Descartes.

  3. 2020 Marie JAZZARA Impact du liquide péritonéal des malades attient de la carcinose dans la modulation de la réponse immunitaire, Université Paris Sorbonne.

  4. 2020 Ayesha Tanveer Behavioral and molecular models of depressed in tumor inoculated mice, Université Paris Saclay

Master 1


  1. 2005 Mansaly Safietou. Effet du stromal growth factor-1 sur la migration des cellules cancéreuses.

Master 1 Sciences et Santé, Paris XIII

  1. 2005 Coupin Nathalie. Reticulogenèse des fibroblastes cornéens in vitro.

Master 1 Sciences et Santé, Paris XIII

  1. 2005 Darvishi Jazi Shiva. Mise en évidence des EPCR fonctionnelles sur les cellules leucémiques in vitro

Master-1, GCDE, Paris XI

  1. 2007 Bermont Cécile. Inhibition de la coagulation par la protéine C activée fixée sur les cellules cancéreuses.

Master 1, Santé Mention Biologie Cellulaire, Paris V

  1. 2019 Assaf Alassaf, Mise en évidence de propriétés anti cancéreuses chez les polyphenoles extraits de plantes, Université Paris-Sud.

  2. 2020 Pauline Grévin. Stratégie d’analyse bioinformatique des marqueurs du cancer, Bioinformatique, Université Paris -7.

Licence


  1. 2008 Calone Ingrid. Effet d’un principe actif, M2YN sur la migration des cellules cancéreuses in vitro.

Licence de Biologie intégrée, Université Cergy Pontoise

  1. 2017 Assaf Al assaf, carcinose péritonéale: interactions entre cellules cancéreuses et fibrines

Licence, (Université Paris Sud- saclay)

Devenir des étudiants


  • Lopez Alemany Roser : Chercheur à l’Institut de Recerca Oncologica, Centre d'Oncologia Molecular, L'Hospitalet de Llobregat, Barcelona, Espagne.

  • Golestaneh Nady: Associate professor. Georgetown university, Washington

  • Ghadira Ibtissem : Professeur en immunologie, Université de Monastir (Tunisie)

  • Merodio de la Quintana Marta : Chercheur à l’Instituto Cientifico Y Tecnologico De Navarra, Pamplona. Espagne.

  • Vincent Loic : Post Doc, Cornell university, NY, USA , Head, Oncology & Immunology Research Sanofi

  • Chen Wenming : Chef du departement d’Hematologie et d’Oncologie au Beijing Chaoyang Hospital. Pékin, Chine

  • Rafii Arash : Professeur Associé, Cornell University.USA

  • ZAHIR Muraf. Professeur de hematologie, Syrie

  • Ducros Elodie : Chargée de misssion et de formation au Laboratoire Innothera à Arcueil, France

  • Sakly Nabil : Professeur Agrégé en Imuunologie, Université de Monastir, Tunisie

  • Lis Raphaël: Associated Professor, Cornell university, NY, USA,

  • Touboul Cyril : MCU-PH, Professor, Université Paris XII

  • Besbes Samaher : Post Doc. College de France

  • Shahid Shah, Professor, Pakistan

  • Mati Ullah, Post Doc, CNRS, Paris Descarte (Paris V).

Collaborations national et Internationale


Depuis mon intégration au CNRS, j’ai eu différents contacts nationaux et internationaux avec qui j’ai réalisé certaines expériences qui m’ont permis d’établir des concepts physio-pathologiques. Il s’agit de ces différents collaborateurs dont l’appartenance citée était celle du moment de la collaboration :

Gregerson Univ. Minneapolis, O. Bertrand, INSERM U 160, Hôpital Beaujon. I. Gery, NIH, Bethesda, R. Stiemer, à l'EMBL, Heidelberg, G. Collenot, Université de Paris VI,

D. Hicks INSERM, Strasbourg, H. Hamm, Chicago University, C. Haye, Institut Curie,

P. Dhermy, Hôtel-Dieu, Paris, MM. Ruchoux de CHU de Lille, B. Pessac ,CNRS, Ivry, H. Kühn, de l'Université de Jülich, Allemagne, M. Chabre et C. Pfister ,CNRS, CEA, Grenoble, J.-P. Collin CNRS URA 290, Université de Poitiers, J. Grassi ,CEN, Saclay, J. Y Perrot Hôtel Dieu de Paris, C. Soria, Université de Rouen, J. Oliver et G. Gabrion,CNRS URA 1197, Université de Montpellier II, E. Schuller, INSERM U 134, Hôpital de la Salpêtrière Paris, R. Motais, CNRS URA 638, CEA, Villefranche sur Mer, M. Kazatchkine et J. Bariéty Broussais Université Paris VI, Paris , D. Barritault, A. Vandewalle, INSERM U 246, A. Nato, CNRS URA 1128, Université de Paris XI, Orsay, A. Trémollières, B. Pineau, CNRS, Gif-sur-Yvette, CNRS, Y. Henry, J. De Buyser, CNRS, Univ Paris XI, Orsay, M. Kreiss, CNRS, Univ Paris XI, Orsay. J.P. Carde, CNRS, Univ. Bordeaux 1. P.Burtin CNRS, Villejuif, S. Fermandjian à l'Institut Gustave Roussy M. Poupot, E. Mery Hôpital Purpan, Toulouse, B. Couderc , Institute Claudius Rigout, Toulouse, C. Soria, Faculté de Pharmacie, Rouen, C. Roisse CEA ST. Louis, A. Rafii, Cornell, USA, branche Qatar, JP Collet, Hôpital pitié salpêtriers, I. Ghedira, Hôpital de Sousse, Tunisie, N. Sakly, Faculté de Pharmacie, Monastir, Tunisie. JM Legeais, Hôtel Dieu de Paris, L. Garderet, Hôpital St.Antoine, Sh. Rafii, Cornell, New York, USA. Z. Michal, Luminy, Marseille. U. Kurbanov, Avicenna University, Tadjikistan. France : LISE-UMR 8235-UPMC: Pr. F. Arefi-Khonsari, Corée du Sud: Institut National du Cancer, Pr San Song, Université de Séoul, Consortium ‘International Society of Precision Cancer Medicine ISPCM, 2018-p’.

Publications

ARTICLES

[1] Boucheix C, Perrot JY, Mirshahi M, Rosenfeld C. A rapid method for the detection of membrane antigens by immunofluorescence and its application to the screening of hybridoma antibodies.

J. Immunol. Methods, 1983, 57, 145-150.

[2] Boucheix C, Soria C, Mirshahi M, Soria J, Perrot JY, Fournier N, Billard M, Rosenfeld C. Characteristics of platelet aggregation induced by the monoclonal antibody ALB6 (Acute Lymphoblastic Leukemia Antigen P 24). Inhibition of aggregation by ALB6 Fab.

FEBS Lett. 1983, 161, 289-295.

[3] Faure JP, Mirshahi M, Dorey C, Thillaye B, de Kozak Y, Boucheix C. Production and specificity of monoclonal antibodies to retinal S-antigen.

Curr. Eye Res. 1984, 3, 867-872.

[4] Mirshahi M, Faure JP, Brisson P, Falcon J, Guerlotté J, Collin JP. S-antigen immunoreactivity in retinal rods and cones and pineal photosensitive cells.

Biol. Cell, 1984, 52, 195-198.

[5] Pfister C, Dorey C, Vadot E, Mirshahi M, Deterre P, Chabre M, Faure JP. La protéine dite "48K" qui interagit avec la rhodopsine illuminée dans les batonnets rétiniens identifiée avec l'"antigène S rétinien" inducteur de l'uvéo-rétinite auto-immune expérimentale.

C.R. Acad. Sci. (Paris), 1984, 299, 261-265.

[6] Perrot JY, Boucheix C, Mirshahi M, Kazatchkine M, Bariéty J. Des anticorps monoclonaux dirigés contre des antigènes de surface de lymphoblastes et de cellules sanguines ou médullaires reconnaissent des constituants du néphron humain.

Néphrologie, 1984, 5, 53-57.

[7] Altério J, Dorey C, Mirshahi M, Faure JP, Barritault D. S-antigen is coded by poly (A)+ mRNA from bovine retina. Biochem. Biophys. Res. Comm., 1985, 132, 934-938.

[8] Boucheix C, Perrot JY, Mirshahi M, Giannoni F, Billard M, Bernadou A, Rosenfeld C. A new set of monoclonal antibodies against acute lymphoblastic leukemia.

Leukemia Res., 1985, 9, 597-604.

[9] Cook J, Fischer G, Boucheix C, Mirshahi M, Jouvin MH., Weiss L, Jack RM., Kazatchkine M.D. Mouse monoclonal antibodies to the human C3b receptor.

Molecular Immunology, 1985, 22, 531-539.

[10] de Kozak Y, Mirshahi M, Boucheix C, Faure JP. Inhibition of autoimmune uveoretinitis by monoclonal antibodies.

Eur. J. Immunol., 1985, 15, 1107-1111.

[11] de Kozak Y, Mirshahi M, Sainte-Laudy J, Thillaye B, Faure JP. Experimental autoimmune uveoretinitis in athymic rats: specific IgE response to retinal S-antigen and disease.

Immunol. Lett., 1985, 9, 109-115.

[12] Enouf J, Bredoux R, Boucheix C, Mirshahi M, Soria C, Levy-Toledano S. Possible involvement of 2 proteins (phosphoprotein and CDS (P 24) in regulation of platelet calcium fluxes.

FEBS Lett., 1985, 398-402.

[13] Mirshahi M, Boucheix C, Collenot G, Thillaye B, Faure JP. Retinal S-antigen epitopes in vertebrate and invertebrate photoreceptors.

Invest. Ophthalmol. Vis. Sci., 1985, 26, 1016-1021.

[14] Soria J, Soria C, Borg JY, Mirshahi M, Piguet H, Tronc C, Fressard C, Caen JP. Platelet aggregation occurs in congenital afibrinogenemia despite the absence of fibrinogen or its fragments in plasma and platelets demonstrated by immunoenzymology.

Brit. J. Haematol., 1985, 60, 503-514.

[15] Soria J, Soria C, Mirshahi M, Samama M. Markers of fibrinogen derivatives used in clinical investigation.

Seminars in Thrombosis, 1985, 11, 129-132.

[16] Soria J, Soria C, Mirshahi M, Boucheix C, Aurengo A, Perrot JY, Bernadou A, Samama M, Rosenfeld C. Conformational change in fibrinogen induced by adsorption to a surface.

J. Colloid and Interface Science, 1985, 107, 204-208.

[17] Collin JP, Mirshahi M, Brisson P, Falcon J, Guerlotté J, Faure JP. Pineal-retinal molecular relationships; distribution of "S-antigen" in the pineal complex.

Neuroscience, 1986, 19, 657-666.

[18] Mirshahi M, Boucheix C, Dhermy P, Haye C, Faure JP. Expression of the photoreceptor specific S-antigen in human retinoblastoma.

Cancer, 1986, 57, 1497-1500.

[19] Mirshahi M, Soria J, Soria C, Perrot JY, Boucheix C. A latex immuno-assay of fibrin/ogen degradation products in plasma using a monoclonal antibody.

Thrombosis Res., 1986, 44, 715-728.

[20] de Kozak Y, Mirshahi M, Boucheix C, Faure JP. Prevention of experimental autoimmune uveoretinitis by active immunization with autoantigen-specific monoclonal antibodies.

Eur. J. Immunol., 1987, 17, 541-547.

[21] de Kozak Y, Mirshahi M, Faure JP.

Rétine et auto-immunité.

Médecine/Sciences, 1987, 3, 207-215.

[22] Mirshahi MC, Soria J, Soria C, Bertrand O, Mirshahi M, Basdevant A.

Glycosylation of human fibrinogen and fibrin in vitro. Its consequences on the properties of fibrin(ogen).

Thromb. Res., 1987, 48, 279-289.

[23] Oliver J, Herbuté S, Mirshahi M, Faure JP, Brisson P, Collin JP. Identification d'une protéine apparentée à l'Antigène S dans les plexus choroïdes de la caille.

C.R. Acad. Sci. (Paris), 1987, 105, série III, 485-491.

[24] Soria C, Mirshahi MC, Soria J, Mirshahi M, Dunnice S, Boucheix C, Beaufils R, Slama R, Caen JP. Dynamic coronary fibrinolysis evaluation in patients with myocardial infarction and unstable angina by specific plasma fibrin degradation products determination.

Thrombosis Res. 1987, 45, 383.

[25] Soria J, Soria C, Mirshahi MC, Mirshahi M, Boucheix C, Pujade E, Perrot JY, Samama M, Bernadou A, Caen JP. Un marqueur spécifique de la thrombolyse : le complexe DDE.

C.R. Acad. Sc. Paris, 1987, 304, série III, 307-311.

[26] Soria J, Soria C, Mirshahi MC, Ma Xi, Mirshahi M, Samama M, Caen JP. Specific determination and identification of cross linked fibrin degradation products in patients under thrombolytic therapy for myocardial infarction.

Seminars in Thrombosis and Haemostasis 1987, 1, 223.

[27] Collin JP, Faure JP, Falcon J, Voisin P, Brisson P, Mirshahi M. Pinéale et rétine.

Médecine/Sciences, 1988, 4, 16-26.

[28] Faivre R, Mirshahi Mc, Ducellier D, Soria C, Soria J, Mirshahi M, Kieffer Y, Bassand JP, Maurat JP, Caen JP. Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thromboembolism.

Thrombosis Res. 1988, 50, 583-589.

[29] Mirshahi MC, Soria C, Soria J, Mirshahi M, Faivre R, Kieffer Y, Bassand JP, Toutlemonde F, Caen JP. Change in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosis.

Thrombosis Res., 1988, 51, 295-301.

[30] de Kozak Y, Mirshahi M, Boucheix C, Faure JP. Modulation of experimental autoimmune uveoretinitis by adoptive transfer of cells from rats immunized with anti-S-antigen monoclonal antibody.

Regional Immunol., 1989, 2, 311-320.

[31] Faivre R., Neuhart E., Mirshahi M., Mirshahi M.C., Soria C., Soria J., Bassand J.P., Caen JP, Maurat JP. Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.

Seminars in Thrombosis and Haemost. 1989, 15, 435-349.

[32] Mirshahi M, Borgese F, Razaghi A, Scheuring U, Garcia-Romeu F, Faure JP, Motais R. Immunological detection of arrestin, a phototransduction regulatory protein, in the cytosol of nucleated erythrocytes.

FEBS Lett., 1989, 258, 240-243.

[33] Mirshahi M, Mirshahi S, Soria C, Soria J, Thomaidis A, Pouliquen Y, Faure JP. Production of proteases type plasminogen activator and their inhibitor in cornea.

Biochem. Biophys. Res. Comm., 1989, 160, 1021-1025.

[34] de Kozak Y, Mirshahi M. Experimental autoimmune uveoretinitis: idiotypic regulation and disease suppression.

Internat. Ophthalmol. 1990, 14, 43-56.

[35] Faure JP, Mirshahi M. S-antigen in non ocular tissues.

Curr. Eye Res., 1990, 9 Suppl., 163-67.

[36] Mirshahi M, Mirshahi S, Soria C, Lorans G, Soria J, Bureau J, Thomaidis A, Pouliquen Y. Sécrétion des activateurs du plasminogène et de leurs inhibiteurs par les fibroblastes de la cornée. Modification de cette sécrétion dans la dystrophie cornéenne cristalline de Schnyder.

C.R. Acad. Sci., Série III ,311, 1990, 253-260.

[37] Mirshahi M, Mirshahi S, Soria C, Perrot JY, Guidalia M, Boucheix C, Soria J. Evolutionary stability of fibrinogen epitopes implicated in fibrin polymerization and in fibrinolysis.

Blood Coagulation and Fibrinolysis, 1990, 1, 427-431.

[38] Scheuring U, Franco M, Fievet B, Guizouarn H, Mirshahi M, Faure JP, Motais R. Arrestin from nucleated red blood cells binds to bovine rhodopsin in a light-dependent manner.

FEBS Lett. 1990,276, 192-196.

[39] Claudy A, Mirshahi M, Soria C, Soria J. Détection of undegraded fibrin and tumor necrosis factor alpha in venous leg ulcers.

J. Am. Acad. Dermatol. 1991, 25, 623-627.

[40] Mirshahi M, de Kozak Y,Tarraf M, Razaghi A, Thillaye B, Faure JP. Early disappearance of alpha-transducin in light-induced photoreceptor degeration in albino rats. Curr. Eye Res., 1991, 10, 993-1000.

[41] Mirshahi M, Nato A, Razaghi A, Mirshahi A, Faure JP. Présence de protéines apparentées à l'arrestine ( antigène- S ) dans des cellules végétales.

C R Acad Sci. Paris, 1991, 312, Série III, 441-448.

[42] Mirshahi M, Razaghi A, Mirshahi S, Tuyen V, Faure JP. Immunopurification of an S-antigen-like protein from human platelets.

Thrombosis Res., 1991, 64, 551 - 558.

[43] Nato F, Goulut C, Mirshahi M, Bourrillon R. Immunological screening of a glycoprotein antigen expressed by Zajdela ascites hematoma cells a normal rat tissues and tumor.

Scand. J. Immunol. 1991, 34, 411-419.

[44] Oliver J, Mirshahi M, Herbuté S, Peraldi- Roux S, Trébuchon L, Brisson P, Collin JP, Faure JP, Gabrion J. Distribution of arrestin-like protein and beta subunit of GTP-binding proteins in quail chroid plexuses.

Cellular Signalling.1991, 3, 461-472.

[45] Mirshahi M, Mirshahi A, Nato A, Agarwal MK. Mineralocorticoid hormone action in plant cells.

Biochem. Biophys. Res. Comm.,1992, 186, 1102-1107.

[46] de Kozak Y, Mirshahi M, Boucheix C, Faure JP. Inhibition of S-antigen-induced experimental autoimmune uveoretinitis by active immunization against anti-idiotypic antibody to an S-antigen epitope.

Regional Immunol., 1992, 4, 168-174.

[47] de Kozak Y, Stiemer RH, Mirshahi M, Frank RW, de Smet M, Faure JP. Humoral immune response against the S-antigen / TNF alpha common epitope in rat EAU suppressed by the monoclonal antibody S2D2.

Curr. Eye Res. 1992, 11 Suppl., 119-126.

[48] Agarwal MK, Mirshahi M. Rat lung possesses the mineralocorticoid receptor.

Biochem. Biophys. Res. Comm.,1992, 183, 405-410.

[49] Mirshahi M, Pagano M, Mirshahi A, Agarwal MK. Generation of polyclonal antibodies against the mineralocorticoid receptor and analysis of mineralocortin in rat myocardium by immunophotochemistry.

Biochem. Biophys. Acta ., 1992; 1120, 17-23.

[50] Mirshahi M, Pagano M, Razaghi A, Lazar G, Agarwal MK. Immunophotochemical analysis of mineralocortinby polyclonal antibodies againstthe native receptor from rat kidny.

Biochem. Med. Metab. Biol., 1992; 47, 133-144.

[51] Mirshahi M, Razaghi A, Vandewalle A, Cluzeaud F, Tarraf M, Faure JP. Immunodetection and localization of protein(s) related to retinal S-antigen (arrestin) in kidney.

Biol. Cell 1992, 76, 175-184.

[52] Mirshahi S, Pujade-Lauraine E, Soria C , Mirshahi M, Frétault J, Bernadou A ,Soria J. D-Dimer and CA-125 levels in patients with ovarian cancer during antineoplastic therapy -Prognostic significance for the success of anticancer treatment.

Cancer, 1992, 69, 2289-2292.

[53] Mirshahi S, Soria J, Lu H, Pujade-Lauraine E, Mirshahi M, Bernadou A, Soria C. Effect of interferon gamma and adriamycine on fibrinolytic activity associated to human monocytes.

Fibrinolysis, 1992, 6, 157-160.

[54] Stiemer RH, Gausepohl H, Mirshahi M, de Kozak Y, Kraft M, Faure JP, Frank RW. Immunological characterization of an immunomodulatory epitope in S-antigen / arrestin with a sequence motif common to tumor necrosis factor alpha.

Immunol. Lett., 1992, 32, 233-240.

[55] Stiemer RH., Westenfelder U, de Kozak Y, Gausepohl H, Mirshahi M, Frank RW, Faure JP, Männel DN. Cytokine induction by immunomodulatory epitopes in S-antigen and tumor necrosis factor alpha.

Curr. Eye Res. 1992, 11 Suppl., 197-202.

[56] Stiemer RH, Westenfelder U, Gausepohl H, Mirshahi M, Gundt A, Frank RW, Männel DN. A common epitope in human tumor necrosis factor alpha and the autoantigen "S-antigen/arrestin" induces TNFalpha production.

J. Autoimmun.1992, 5, 15-26.

[57] Mirshahi M, Mirshahi A, Nato A, Agarwal MK. Receptor mediated mineralocorticoid action in alga cell mutats

FEBS lett.1992; 314, 237-240.

[58] Mirshahi SS, Vasse M, Soria C,Moreau JF, Taupin JL, Mirshahi M, Pujade-Lauraine E, Bernadou A, Soria J. Incubation of monocytes with adriamycin increases secretion of hepatocyte stimulating factor for fibrinogen biosynthesis and urokinase-associated to cell membrane.

Blood Coagulation and Fibrinolysis 1993 , 4, 149-152.

[59] Vasse M, Mirshahi SS, Soria J, ,Mirshahi M , Borg JY, Monconduit M, Soria C. Potent activity of peripheral lymphocytes on monocytes in induced hepatocyte stimulating factor and urokinase.

Blood Coagulation and Fibrinolysis 1993, 4, 143-149.

[60] Agarwal MK, Mirshahi F, Mirshahi M, Rostene W. Immunochemical detection of the mineralocorticoid receptor in rat brain.

Neuroendocrinology 1993, 58, 575-580.

[61] Mirshahi M, Thillaye B,Tarraf M, deKozak Y, Faure JP. Light-induced changes in S-antigen (arrestin) localization in retinal photorecetors; difference between rods and cones and defective process in RCS rat retinal dystrophy.

Eur. J. Cell Biol. 1994,63, 61-67.

[62] Agarwal MK, Mirshahi M, Braq S, Jullienne A, Leblanc N, Stibon F, Guern J. Nicotiana Tabacum contains a putative mineralocorticoid receptor.

Biochem. Biophys. Res. Comm.,1994 , 200; 1230-1228.

[63] Pagano M, Mirshahi M, Mirshahi F, Monnot M, Lazar G, Chassaing CG, Fermandjian S, Agarwal MK. Properties of the mineralocorticoid receptor immunopurfied from bovin kidney.

Biochem. Pharmacol. 1994; 48, 1163-1169.

[64] Dubertret G, Mirshahi A, Mirshahi M, Gerardhirne C,Tremolieres A. The d3-transe-hexadecenoic acid-containing phoshatidylinoglycerol is involved in the biogenesis of the light-harvesting hlorophyll A/B-protein complex of chlamydomonas reiharditti; evidence for in vivo manupulaions of lipid composition in mutants.

Eur. J. Biochem., 1994, 113, 801-807.

[65] Mirshahi SS, Soria J, Mishal Z, Mirshahi M, Lenoble M, Soria C. Pentoxifilline inhibits calcium mediated activation by tumor necrosis factor in humain monocytes.

Cell. Pharmacol., 1994, 1,63-66.

[66] Mirshahi SS, Soria J. Mirshahi M, Soria C, Lenoble M, Cambazard F, Claudy A. Expression elastase and fibrin in in venous leg ulcer biopsies. A pilot study of pentoxifylline versus placebo.

J. Cardiovasc. Pharmacol. 1995, 25,101-105

[67] Lebrazi J, Abdelouahed M, Mirshahi M, Gouin I, Samama M, Lecompte T. Streptokinase and APSAC inhibit platelet aggregation in vitro by fibrinogenolysis: effet of plasma fibrinogen degradation products X and E.

Fibrinolysis, 1995, 9, 113-119.

[68] Lebrazi J, Helft G, Mirshahi M, Gouin I, Samama M, Lecompte T. Human anti streptokinase antibodies induce platelet aggregation in a FC/CD32 dependent manner.

Thrombosis Hemostasis 1995, 74 938-942.

[69] Lopez-Alemany R, Mirshahi S, Faure JP, Pouliqeun Y, Burtin P, Mirshahi M. Binding of plasminogen to corneal fibroblasts and their extracellular matrix. Evidence for a receptor in cell membranes.

Fibrinolysis, 1995, 9; 223-229 .

[70] Abdelouahed M, Elalamy S, Lebrazi J, Gerard H, Mirshahi M, Leucrubier ., Samama M, Lecompte T. Streptokinase modifies in vitro platelet aggregation by two mechanisms: defect by fibrinogenolysis and activation by immunological reaction.

Platelet 1995, 6; 317-325.

[71] Agarwal MK, Mirshahi F, Mirshahi M, Braq S, Chentoufi J, Julienne A, Marie JP. Receptor mediated physiological action of Mineralocorticoids in rat osteoblastic cells .

Americ. J. Physiol. 1996, 270 (cell physiol 39)C1088-C1095.

[72] Mirshahi , Nicola C, Mirshahi A, Hecquet C, Dhermy F, Faure JP, Agarwal MK. The mineralocorticoid hormone receptor and action in the eye.

Biochem. Biophys. Res. Comm., 1996, 219; 150-156.

[73] Janabi N, Mirshahi A, Wolfrom C, Mirshahi M, Tardieu M. Effect of interferon- γ and TNF- α on the differentiation /activation of humain glial cells; implication for TNF alpha receptor-1

Res. Virol. (Institut Pasteur) 1996, 147; 147-153.

[74] Mirshahi S, Soria J, Nelles L, Soria C, Faure JP, Pouliquen Y, Mirshahi M. Plasminogen activators in human corneal fibroblasts, cellular localization and regulation.

Fibrinolysis 1996, 10, 255-262.

[75] Nato A, Henry Y, De Buyser J,Mirshahi M, Lavergne D, Jean C, Cavalcante-Alves M, Ducreux G , Tichtinsky G, Jouannic S, Hamal A ,Kreis M. Expression of signaling molecules during wheat somatic embryogenesis.

Plant Tissue Culture and Biotechnology. 1996, 2, 212-214.

[76] Mirshahi M, Mirshahi A, Sedighian R, Hecquet C, Faure JP, Agarwal MK. Immunochemical demonstration of the mineralocorticoid receptor in ocular tissues

Neuroendocrinology.1997, 65; 70-78.

[77] Nato A, Mirshahi A, Mirshahi M, Faure JP, Lavergne D, Ducreux G, Henry Y. Signal transduction molecules expressed during wheat differantiation via somatic embryogenesis.

Plant Physiology, 1997, 113; 801-807.

[78] Razaghi A, Bonaly J, Chacun H, Faure JP, Mirshahi M, Barque JPh. Immunodetection of a protein related to mammalian arrestin in Eauglena gracilis.

Biochem. Biophys. Res. Comm. 1997, 233; 601-605.

[79] Nicolas C, Ghedira I, Faure JP, Mirshahi M. Identification of arrestin-like proteins in a human megakaryocytic cell line (HEL cells).

Platelet, 1998, 9; 55-62.

[80] Emadi S, Mirshahi M, Elalamy I, Nicolas C, Vargaftgi BB., Hatmi M. Cellular source of human platelet secretory phospholipase A2

Brit. J. of Hemat. 1998, 100, 365-373.

[82] Mirshahi M, Nicolas C, Agarwal MK.Enhanced activation of the mineralocorticoid receptor in genetically hypertensive rat.

Biochem. Biophys. Res. Comm. 1998, 244, 120-125.

[82] Pouliquen Y, Bureau J, Mirshahi M, Mirshahi SS, Assouline M, Lorens G. Keratoconus and inflammatory processes

Bull Soc Belge Ophtalmol. 1996, 262, 25-28.

[83] Mirshahi M, Mirshahi S, Golestaneh N, Nicolas C Mishal Z, Agarwal MK. Mineralocorticoid hormone receptor and the epithelial sodium channel in a human leukemic cell line.

Endocr. Res.1998, 24, 455-459.

[84] Lafont A, Durand E, Vilde F, Moreyea C, Drechsel S, Mirshahi S, Mirshahi M, Guérot C, Lemarchand P. Thrombus generation after adenovirus-mediated gen transfer into atherosclerotic arteries .

Human Gene Therapy . 1999, 10, 2795-2800.

[85] Nicolas C, Ghedira I, Faure JP, Mirshahi M.

Arrestin -related proteins in ocular tissues.

Inves. Ophtalmol. Vis.Sci. 1999,40, 1812-1818.

[86] Mirshahi M, Nicolas C, Mirshahi S, Golestaneh N, d'Hermies F, Agarwal MK. Immunochemical analysis of the sodium channel in rodent and human eye.

Ex. Eye Res.1999, 69: 21-32.

[87] Mirshahi M, Camoin L, Nicolas C, Ghedira I, Cozette J, Faure JP. Copurification of glycolytic enzymes with retinal S-antigen (arrestin) by hydroxyapatite agarose chromatography of bovine retina.

Curr. Eye Res.1999, 18, 327-334.

[88] Agarwal MK, Mirshahi M. General overview of mineralocorticoid hormone action

Pharmacol.Therap. 1999, 84, 273-326.

[89] Merodio M, Campanero MA., Mirshahi T, Mirshahi M, Irachi JM. Development of a new and sensitive method for the determination of ganciclovir by reversed-phase hirh performance liquid chromatography.

Journal of Chromatography , 2000, 870, 159-167.

[90] Mirshahi M, Golestaneh N, Valamanesh F, Agarwal MK, Paradoxal effects of mineralocorticoids on the ion gate sodium channel in embryologically diverse cells.

Biochem. Biophys. Res. Comm. 2000, 270, 811-815.

[91] Mirshahi M, Mirshahi S, Golestaneh N, Mishal Z, Nicolas C, Hecquet C, and Agarwal MK, Demonstration of the mineralocorticoid hormone receptor and action in human leukemic cell lines

Leukemia , 2000, 14, 1097-1104.

[92] Nicola C, Ghedira I, Stiemer R, Teufel B, Hecquet C, Faure JP, Mirshahi M. Identification of visual arrestin(S-antigen) in retinal pigmented epithelial cells.

Curr Eye Res. 2000, 21, 677-83.

[93] Golestaneh N, Nicolas C, Picaud S, Ferarri P, Mirshahi M. The mineralocorticoid receptor in rodent retina, ontogeny and molecular identity.

Curr Eye Res. 2000, 21, 703-9.

[94] Merodio M, Irache JM, Eclancher F., Mirshahi M., Villarroya H. Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis.

J. Drug Target. 2000, 8, 289-303.

[95] Lounes KC, Soria C, Mirshahi SS, Desvignes P, Mirshahi M, Bertrand O, Bonnet P, Koopman J, Soria J. Fibrinogen Ales: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".

Blood. 2000, 96, 3473-9.

[96] Mirshahi M, Mirshahi S, Golestaneh N, Nicolas C, Mishal Z, Lounes KC, Hecquet C, Dagonet F, Pouliquen Y, Agarwal MK. Mineralocorticoid hormone signaling regulates the 'epithelial sodium channel' in fibroblasts from human cornea.

Ophthalmic Res. 2001, 33, 7-19.

[97] Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton.

Biochem Biophys Res Commun. 2001, 280,1300-6.

[98] Golestaneh N, De Kozak Y, Klein C, Mirshahi M. Epithelial sodium channel and the mineralocorticoid receptor in cultured rat Muller glial cells.

Glia. 2001, 33, 160-8.

[99] Gerotziafas GT, Elalamy I, Lecrubier C, Lebrazi J, Mirshahi M, Potevin F, Lecompte T, Samama M.M. The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia.

Blood Coagul Fibrinolysis. 2001, 12, 511-20.

[100] Merodio M, Irache JM, Valamanesh F, Mirshahi M. Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats

Biomaterials ; 2002, 23, 1587-1594.

[101] Merodio M, Espuleas MS, Mirshahi M, Arendo A, Irache JM. Efficacy of Ganciclovir-loaded Nanoparticles in humain cytomegalovirus (HCMV)-infected cells.

Journa.of Drug Targeting, 2002, 10, 231-238.

[102] Mirshahi M, Ayani E, Nicolas C, Golestaneh N, Ferrari P, Valamanesh F, Agarwal MK. The blockade of mineralocorticoid hormone signaling provokes dramatic teratogenesis in cultured rat embryos.

Int J Toxicol. 2002 , 21, 191-199.

[103] Merodio M, Espuelas MS, Mirshahi M, Arnedo A, Irache JM. Efficacy of ganciclovir-loaded nanoparticles in human cytomegalovirus (HCMV)-infected cells.

J Drug Target. 2002,10, 231-238.

[104] Golestaneh N, Picaud S, Mirshahi M. The mineralocorticoid receptor in rodent retina: Ontogeny and molecular identity

Mol. Vis. 2002, 8,221-225

[105] Chen WM, Zhu J, Mirshahi F, Soria J, Mirshahi M, Soria C. Thalidomide inhibits the angiogenic activity of cutlure supernatants of multiple myeloma cell line.

Zhonghua Xue Ye Xue Za Zhi. 2002, 23, 520-523.

[106] Chen WM, Wu Y, Zhu JZ, Soria J, Mirshahi M. Study on angiogenesis of multiple myeloma in vitro

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2002,10, 310-4. Chinese.

[107] Mirshahi T, Irache JM, Nicolas C, Mirshahi M, Faure JP, Geugen J, Hequet C, Orechioni AM, Adoptive immune responses of legumin nanoparticles

J. Drug targeting 2002, 10, 625-631.

[108] Vincent S, Mirshahi M, Nicolas C, Adenis C, Dhellemes P, Soto Ares G, Maurage CA, Baranzelli MC, Giangaspero F, Ruchoux MM. Larg – cell medulloblastoma with arrestin-like protein expression.

Clin.Neuropath., 2003, 22, 1-9 .

[109] Lopez-Alemany R, Longstaff C, Hawley S, Mirshahi M, Fabregas P, Jardi M, Merton E, Miles LA, Felez J. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.

Am J Hematol. 2003,72, 234-242.

[110] Mirshahi M, Agarwal MK. Receptor- mediated adrenocorticoid hormone signaling in ocular tissues.

Biochem. Pharmacol.2003; 65/8 pp 1207 - 1214

[111] Mirshahi M, valamanesh F, Golestaneh N, Mirshahi P, Vincent L, tang R, Agarwal MK. Mineralocorticoid hormones exert dramatic effects on pluripotent human stem cell progeny.

Int J Toxicol. 2003, 22, 297-304.

[112] Chen W, Valamanesh F, Mirshahi T, Soria J, Tang R, Agarwal MK, Mirshahi M. Aldosterone signaling modifies capillary formation by human bonmarrow endothelial cells.

Vascular pharmacology 2004, 40, 269-277.

[113] Durand E, Scoazec A, Lafont A, Boddaert J, Al Hajzen A, Addad F, Mirshahi M, Desnos M, Tedgui A, Mallat Z. In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion.

Circulation. 2004, 109, 2503-6.

[114] Sakly N, Mirshahi P, Soria J, Ghedira I, Mirshahi M. Anti-Endothelial Cell Antibodies Determination by Cyto-ELISA: A Comparative Study between Three Cell Types Used as Substrates.

Ann N Y Acad Sci. 2005, 1050, 201-209.

[115] Mirshahi P, Toprak SK, Faussat AM, Dubrulle S,Marie JP, Soria C, Soria J, Mirshahi M. Malignant haematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.Biochem Biophys Res Commun, 2006, 349, 1003-1010.

[116] Ducros E, Berthaut A, Mirshahi P, Lemarchand S, Soria J, Legeais JM, Mirshahi M.

Expression of extracellular matrix proteins fibulin-1 and fibulin-2 by human corneal fibroblasts.

Curr Eye Res. 2007, 32, 481-490.

[117] Ducros E, Berthaut A, Mirshahi SS, Faussat AM, Soria J, Agarwal MK, Mirshahi M.

Aldosterone modifies hemostasis via upregulation of the protein-C receptor in human vascular endothelium.

Biochem Biophys Res Commun. 2008, 373, 192-196.

[118] Zaher M, Akrout I, Mirshahi M, Kolb JP, Billard C. Noxa upregulation is associated with apoptosis of chronic lymphocytic leukemia cells induced by hyperforin but not flavopiridol.

Leukemia. 2009, 23, 594-596.

[119] Lis R, Lacroix-Triki M, Mirshahi P, Mirshahi M, Rafii A, Fournie JJ , Poupot M. Role of the tumoral micro-environment in metastatic dissemination of breast cancers. Bulletin du cancer, 2008, 95: Sp. Iss.: S51-S51.

[120] Ducros E, Berthaut A, Mirshahi P, Lemarchand S, Soria J, Legeais JM, Mirshahi M.

Implication de la Fibuline 1 dans les phénomènes de cicatrisation.

JPC 2008, 13, 7-11.

[121] Rafii A, Mirshahi P , Poupot M, Faussat AM, Simon A.,Ducros E., Mery E., Couderc B., Lis R., Capdet J., Bergalet J., Querleu D., Dagonnet F., Fournié J.J., Marie J.P., Pujade-Lauraine E., Favre G., Soria J., Mirshahi M. Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours.

Plos One . 2008, 3, e3894.

[122] Mirshahi P, Rafii A , Vincent L, Berthaut A, Varin R, Kalantar G, Marzac C, Calandini OA., Marie JP, Soria C, Soria J, Mirshahi M . Functional abnormalities of bone marrow stromal cells derived from acute leukemia stem cells

Leukemia. 2009 Jun;23(6):1039-48.

[123] Sakly N, Mirshahi P, Ducros E, Soria J, Ghedira I, Mirshahi M. Clinical significance of increased angiogenic activity in sera of patients with systemic lupus erythematosus.

Lupus , 2009, 18; 705-712.

[124] Ducros E, Mirshahi SS, Bermot C, Mirshahi M. Endothelial protein C receptor functionality analysis on living cells.

Open Biochem J, 2009, 13, 3, 49-54

[125] Mirshahi M, Mirshahi P, Negro S, Soria J, Sreekumar PK, Kotnala S, Therwath A, Chatterji A. Extract of Indian Green Mussel, Perna viridis (L.) shows inhibition of blood capillary formation in vitro.

PertanikanJ. Tropic. Agric. Sci. 2009, 32, 35-42,

[126] Berthaut A, Mirshahi P, Benabbou N, Azzazene D, Bordu C, Therwath A, Legeais JM, Mirshahi M. Vascular endothelial growth factor receptor-1 (VEGFR-1) expression in human corneal fibroblast decreased with age.

Mol Vis. 2009 Sep 29;15:1997-2007.

[127] Mirshahi M, Hospicells, quand organisme aide les cellules cancéreuses à résister à la chimiothérapie,

Biofutur , septembre 2009.

[128] Martinet L, Poupot R, Mirshahi P, Rafii A, Fournié JJ, Mirshahi M, Poupot M. Hospicells derived from ovarian cancer stroma inhibit T cell immune responses.

Int J Cancer. 2010,126, 2143-52.

[129] Pasquet M, Golzio M, Mery E, Rafii A, Benabbou N, Mirshahi P, Hennebelle I, Bourin P, Allal B, Teissie J, Mirshahi M, Couderc B. Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis.

Int J Cancer, 2010,126, 2090-101.

[130] Karroum A, Mirshahi P, Benabbou N, Faussat AM, Soria J, Therwath A, Mirshahi M, Hatmi M. Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways

Cancer Lett. 2010, 295, 242-251.

[131] Berthaut A, Mirshahi P, Benabbou N, Ducros E, Agra A, Therwath A , Legeais JM, Mirshahi M. Insulin growth factor promotes human corneal fibroblast network formation in vitro. Invest. Ophtalmol. Vis. Sci.2010, Jul 14.

[132] Lis R, Capdet J, Mirshahi P, Lacroix-Triki M, Dagonnet F, Klein C, Mirshahi M, Fournié JJ, Rafii A, Poupot M. Oncologic trogocytosis with Hospicells induces the expression of N-cadherin by breast cancer cells.

Int J Oncol. 2010;37, 1453-61.

[133] Lis R, Touboul C, Mirshahi P, Ali F, Mathew S, Taha Z R, Maleki M, Abdalla A S, Raynaud C M, Querleu D ,Malek J , Mirshahi M, Rafii A. Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12.

Int J Cancer. 2011 Feb 1;128(3):715-25.

[134] Gest C, Mirshahi P, Li H, Pritchard LL, Joimel U, Blot E, Chidiac J, Poletto B, Vannier JP, Varin R, Mirshahi M, Cazin L, Pujade-Lauraine E, Soria J, Soria C. Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.Cancer Lett. 2011 Nov 25.

[135] Zaher M, Mirshahi M, Nuraliev Y, Sharifova M, Bombarda I, Marie JP, Billard C.The BH3-only protein Noxa is stimulated during apoptosis of chronic lymphocytic leukemia cells triggered by M2YN, a new plant-derived extract. Int J Oncol. 2011 Oct;39(4):965-72

[136] Decaup E, Mirshahi P, Rafii A, Mirshahi M, Fournié JJ, Poupot M. Oncologic Trogocytosis Protects Tumour Stromal Cells from γδ Cell Cytotoxicity. Journal of Life Sciences, 2011, 12, 986-995

[137] Karroum A, Mirshahi P, Faussat AM, Therwath A, Mirshahi M, Hatmi M. Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions.

Eur J Pharmacol. 2012 Jun 15;685(1-3):1-7.

[138] Ducros E, Mirshahi S, Azzazene D, Camilleri-Broët S, Mery E, Al Farsi H, Althawadi H, Besbes S, Chidiac J, Pujade- Lauraine E, Therwath A, Soria J, Mirshahi M. Endothelial protein C receptor expressed by ovarian cancer cells can be a biomarker of cancer expansion

Int J Oncol. 2012 Aug;41(2):433-40. doi: 10.3892/ijo.2012.1492.

[139] Mirshahi P, Berthaut A, Ducros E, Soria J, Agarwal MK., Mirshahi M. Pleiotropic effect of aldosterone on human endothelial cells in vitro . The Open Cell Signaling Journal, 2012, 4, 1-8

[140] Lis R, Touboul C, Mirshahi M, Rafii A, Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties PLoS One. 2012;7(5):e38340.

[141] Bhatt S, Pulpytel J, Mirshahi M, Arefi-Khonsari F. Nano sized poly (ε-caprolactone)-poly (ethylene glycol) coatings developed by catalyst free plasma assisted copolymerization process for biomedical applications.

RSC Adv., 2012, DOI: 10.1039/C2RA21211K

[142] Castells M, Thibault B, Mery E, Golzio M, Pasquet M, Hennebelle I, Bourin P, Mirshahi M, Delord JP., Querleu D, Couderc B. Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages.

Cancer Lett. 2012 Jul 20.

[143] Bhatt S, Pulpytel J, Mirshahi M, Arefi-Khonsari F. Catalyst-Free Plasma-Assisted Copolymerization of Poly(ε-caprolactone)-poly(ethylene glycol) for Biomedical Applications

ACS, Macro letter, 2012, pp 764–767, DOI: 10.1021/mz300188s.

[144] Ducros E, Mirshahi SS, Faussat AM, Mirshahi P, Dimicoli S, Tang R, Pardo J, Ibrahim J, Marie JP, Therwath A, Soria J, Mirshahi M. Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies.

Cancer Med. 2012 Oct;1(2):261-7. doi: 10.1002/cam4.11.

[145] Touboul C, Lis R, Al Farsi H, Raynaud CM., Warfa M, Althawadi H, Mery E, Mirshahi M, Rafii A. Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model.

J Transl Med. 2013 Jan 31;11:28. doi: 10.1186/1479-5876-11-28.

[146] Varin R, Mirshahi S, Mirshahi P, Klein C. Jamshedov J, Chidiac J, Perzborn E, Mirshahi M, Soria C, Soria J. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.

Thromb Res. 2013 Mar;131(3):e100-9. doi: 10.1016/j.thromres.2012.11.029.

[147] Pasquier J, Guerrouahen BS, Al Thawadi H, Ghiabi P, Maleki M, Abu-Kaoud N, Jacob A,Mirshahi M, Galas L, Rafii S, Le Foll F., Rafii A. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance.

J Transl Med. 2013 Apr 10;11:94. doi: 10.1186/1479-5876-11-94.

[148] Bhatt S., Pulpytel J., Mirshahi M., Arefi-Khonsari F. Plasma Co-polymerized Nano Coatings - As a Biodegradable Solid Carrier for Tunable Drug Delivery Applications

Polymer, 2013, 54; 18, 4820-4829

[149] Bhatt S, Pulpytel J, Mirshahi M, Arefi-Khonsari F. Nano thick poly(e-caprolactone)-poly(ethylene glycol) coatings developed by catalyst-free plasma assisted co polymerization process for biomedical applications

RSC Adv., 2012,2, 9114-9123 DOI: 10.1039/C2RA21211K

[150] Benabbou N, Mirshahi P, Cadillon M, Soria J, Therwath A, Mirshahi M. Hospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2/STAT3 signaling pathway in an ovarian cancer cell line.

Int J Oncol. 2013 Sep;43(3):685-94. doi: 10.3892/ijo.2013.2017.

[151] Azzazene D, Al Thawadi H, Al Farsi H, Besbes S, Geyl C, Mirshahi S, Pardo J, Faussat AM, Jeannette S, Therwath A, Pujade-Lauraine E, Mirshahi M. Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.

Int J Oncol. 2013 Jul 18. doi: 10.3892/ijo.2013.2021.

[152] Kurbonov U, Dustov A, Barotov A, Khidirov M, Mirojov G, Rahimov Z, Navjuvonov N, Rizoev E, Olimov N, Goibov A, Karim-Zade B, Rakhmatov M, Muminjonov S, Didari A, Irgasheva J, Bobokhojaev O, Gulmuradov T, Therwath A, Rakhmonov S, Mirshahi M. Intracoronary Infusion of Autologous CD133+ Cells in Myocardial Infarction and Tracing by Tc99m MIBI Scintigraphy of the Heart Areas Involved in Cell Homing, Stem Cells International, Volume 2013 (2013), Article ID 582527.

[153] Mirshahi S , Soria C, Kouchakji B, Kierzek G, Borg JY, Varin R, Chidiac J, Drouet L, Mirshahi M., Soria J. A new combinational assay for identifying patients with suspected venous thromboembolism.

PLoS One. 2014 Mar 24;9(3):e92379. doi: 10.1371/journal.pone.0092379. eCollection 2014

[154] Bonneau C, Cortez A, Lis R, Mirshahi M, Fauconnier A, Ballester M, Daraï E, Touboul C. Lymphatic and nerve distribution throughout the parametrium.

Gynecol Oncol. 2013 Dec; 131(3):708-13. doi: 10.1016/j.ygyno.2013.10.006. Epub 2013 Oct 11.

[155] d'Alessio PA, Mirshahi M, Bisson JF, Béné MC. Skin Repair Properties of d-Limonene and Perillyl Alcohol in Murine Models.

Antiinflamm Antiallergy Agents Med Chem. 2013 Oct 27.

[156] Bhatt S, Pulpytel J, Mori S, Mirshahi M, Arefi-Khonsari F. Cell repellent coating developed by an open air atmospheric presseure non-equilibrium Aragon plasma jet for biomedical application.

Plasma process and Plymer, 2013, DOI 10.1002/ppap. 201300076. 2014, 11 (1), 24-36

[157] Benabbou N, Mirshahi P, Bordu C, Faussat AM, Tang R, Therwath A, Soria J, Marie JP, Mirshahi M. A subset of bone marrow stromal cells regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line. Int J Oncol. 2014 Oct;45(4):1372-80. doi: 10.3892/ijo.2014.2569. Epub 2014 Jul 29.

[158] Bhatt S, Pulpytel J, Mori S, Mirshahi M, Arefi‐Khonsari F. Cell Repellent Coatings Developed by an Open Air Atmospheric Pressure Non‐Equilibrium Argon Plasma Jet for Biomedical Applications. Plasma Processes and Polymers 11 (1), 24-36. 2014.

[159] Sakly K, Maatouk M, Hammami S, Harzallah O, Sakly W, Feki S, Mirshahi M, Ghedira I, Sakly N. HLA-G 14bp insertion/deletion polymorphism and its association with sHLA-G levels in Behçet's disease Tunisian patients. Hum Immunol. 2015 Oct 28. pii: S0198-8859(15)00537-6. doi: 10.1016/j.humimm.2015.10.016.

[160] Mirshahi S , Pritchard LL , Pocard M , Mirshahi M , Soria J. Pathogenesis and Diagnosis of Venous Hypercoagulable States in Cancer . Journal of Hematology & Thromboembolic Diseases. 2015, 3:3 http://dx.doi.org/10.4172/2329-8790.1000211.

[161] Kurbon U, Dodariyon H, Davlatov A, Janobilova S, Therwath A, Mirshahi M. Surgical treatment of bronchial asthma by resection of the laryngeal nerve. BMC Surg. 2015 Oct 8;15(1):109. doi: 10.1186/s12893-015-0093-2.

[162] Besbes s, Althawadi H , Alfarsi H, Mirshahi Sh, Tang R , Fava F , PardoJ , Huessler EM, Galtier T , Ghedira I Soria J, Marie JP , Mirshahi M. Endothelial protein C receptor gene 6936A/G single-nucleotide polymorphism as a possible biomarker of thrombotic risk in acute myeloid leukemia . Molecular and clinical oncology 3: 1280-1284, 2015.

[163] Bhatt s, Pulpytel J, Mori SH, Mirshahi M, Arefi-Khonsari F, Cell Resistant Peptidomimetic Poly (2-ethyl-2-oxazoline) Coatings Developed by Low Pressure Inductively Excited Pulsed Plasma Polymerization for Biomedical Purpose. Plasma process and polymer, 2015, DOI: 10.1002/ppap.201400169.

[164] Althawadi H, Alfarsi H, Besbes S, Mirshahi S, Ducros E, Rafii A, Pocard M, Therwath A, Soria J, Mirshahi M. Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironment. Oncol Rep. 2015 Aug;34(2):603-9. doi: 10.3892/or.2015.4061. Epub 2015 Jun 15.

[165] Besbes S, Mirshahi M, Pocard M, Billard C New dimension in therapeutic targeting of BCL-2 family proteins. Oncotarget. 2015 May 30;6(15):12862-71, Review.

[166] Besbes S, Mirshahi M, Pocard M, Billard C. Strategies targeting apoptosis proteins to improve therapy of chronic lymphocytic leukemia. Blood Rev. 2015 Sep;29(5):345-50. doi: 10.1016/j.blre.2015.03.005. Epub 2015 Mar 31, Review.

[167] Mirshahi M, Le Marchand S. Co-purification of arrestin like proteins with alpha-enolase from bovine myocardial tissues and the possible role in heart diseases as an autoantigen. Biochem Biophys Res Commun. 2015 May 8;460(3):657-62. doi: 10.1016/j.bbrc.2015.03.086. Epub 2015 Mar 27.

[168] Kaci R , Shahid S, Lo Dico R, Brouland JP , Therwath A , Pocard M, Mirshahi M. Neural Signature Expressed by Cells from Ovarian Carcinoma (A Case Report) . Immunochem Immunopathol 1: 111. doi:10.4172/2469-9756.1000111.

[169] Laemmel E, Segal N, Mirshah M, Azzazene D, Le Marchand S, Wybier M, Vicaut E, Laredo JD. Deleterious Effects of Intra-Arterial Administration of Particulate Steroids on Microvascular Perfusion in a Mouse Model. Radiology, 2016 Jan 13:142746.

[170] Besbes S, Pocard M, Mirshahi M, Billard C. The first MCL-1-selective BH3 mimetics have therapeutic potential for chronic lymphocytic leukemia. Crit Rev Oncol Hematol. 2016 Apr;100:32-6. doi: 10.1016/j.critrevonc.2016.02.003. Review.

[171] Sharofova M, Nuraliev Y, Ganiev Kh, Suhrobov P, Zubaydova T, Samandarov N, Mirshahi M. Acid dietary as diabetogenic risk factors, IESRJ, 2(9), 51-56, 2016

[172] Bhatt S, Valamanesh F, Pulpytel J, Lo Dico R, Baiyukha A, Al-Dybiat I, Pocard M, Arefi-Khonsari F, Mirshahi M. Radio-frequency plasma polymerized biodegradable carrier for In vivo release of cis-platinum. Oncotarget. 2016 Jul 29. doi: 10.18632/oncotarget.10932.

[173] Mirshahi S, Pujade-Lauraine E, Soria C, Pocard M, Mirshahi M, Soria J. Cancer Res (letter) . 2016 Aug 15;76(16):4909. doi: 10.1158/0008-5472.CAN-16-0138.

[174] Besbes S, Shah S, Al-Dybiat I, Mirshahi S, Helfer H, Najah H, Fourgeaud C, Pocard M, Ghedira I, Soria J, Mirshahi M.Thrombopoietin Secretion by Human Ovarian Cancer Cells.Int J Cell Biol. 2017;2017:1873834. doi: 10.1155/2017/1873834.

[175] Jouvin I, Najah H, Pimpie C, Canet Jourdan C, Kaci R, Mirshahi M, Eveno C, Pocard M. Reduction of carcinomatosis risk using icodextrin as a carrier solution of intraperitoneal oxaliplatin chemotherapy. Eur J Surg Oncol. 2017 Jun;43(6):1088-1094. doi: 10.1016/j.ejso.2016.12.009. Epub 2017 Jan 9.

[176] Irgasheva J, Aldybiat I, Shukurov FA, MirshahI M, Physiological role of bone marrow adult stem cell CD133+, Avicenna Bulletin. 2018, 19; 2, 177-182, 2017, doi: 10.25005/2074-0581-2017-19-2-177-182.

[177] Miailhe G, Arfi A, Mirshahi M, Eveno C, Pocard M, Touboul C. A new animal model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing mice in the treatment of peritoneal carcinomatosis of ovarian origin.J Visc Surg. 2017 Nov 3. pii: S1878-7886(17)30125-X. doi: 10.1016/j.jviscsurg.2017.10.008.

[178] Kurbonov U, Davlatov A, Janobilova S, Kurbanov, Mirshahi M, The use of temporo-parietal fascia flap for surgical treatment of traumatic auricle defects. Plast Reconstr Surg Glob Open. 2018 May 2;6(5):e1741. doi: 10.1097/GOX.0000000000001741. eCollection 2018.

[179] Irgasheva1 J, Baratov A, Mirshahi M. Human stem cells and cardiac revitalization (new experience in Tajikistan) Avicenna Bulletin, 2018. DOI: 10.25005/2074-0581-2018-20-2-3-176-180.

[180] Pasquier J, Gosset M, Geyl C, Hoarau-Véchot J, Chevrot A, Pocard M, Mirshahi M, Lis R, Rafii A, Touboul C. CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer. Mol Cancer. 2018 Feb 19;17(1):47. doi: 10.1186/s12943-018-0787-z.

[181] Shah S, Fourgeaud C, Derieux S, Mirshahi S, Contant G, Pimpie C, Lo Dico R, Soria J, Pocard M, Mirshahi M. The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma. Oncotarget. 2018 Sep 18;9(73):33778-33787. doi: 10.18632/oncotarget.26042. eCollection 2018 Sep 18.

[182] Baitukha A, Iman Al-Dybiat I, Valinataj-Omran A, Pulpytel J, Pocard M, Mirshahi M, Arefi-Khonsari F Low pressure plasma processing of collagen membranes for anti-cancer drug delivery

J Material Sci Eng, 2018, 7: 499. doi: 10.4172/2169-0022.1000499.

[183] Soria J, Mirshahi S, Mirshahi S. Q, varin R, Pitchard L, Soria C, Mirshahi M. Fibrinogen alpha C demain: Its importance in physiopathology, Rec. Pract. Thromb. Haemost. 2019, 1-11. Diol: 10.1002/rth2.12183.

[184] Sharofova M, Sagdieva Sh., Abdullaev S, Maslov V, Mirshahi M. First main series of transition elements from atomic number 22 to 29 detected in the plants from Tajikistan Areas, Proceding of Tajikistan Academy of Science,2018;61(4):350-359.

[185] Ullah M, Azazzen D, Kaci R, Benabbou N, Pujade Lauraine E, Pocard M, Mirshahi M. High Expression of HLA-G in ovarian carcinomatosis: the role of interleukin-1ß, Neoplasia. 2019 Mar;21(3):331-342. doi: 10.1016/j.neo.2019.01.001.

[186] Sharofova M, Al dybiat I, Sagdieva Sh., Bourkhonova N, Nuraliev Y3, Rahimi F, Mirshahi M. Molecular approach to determine the hot and cold temperaments in plants according Avicenna concepts, the role of Magnesium. Avicenna Bulletin, 2019. doi: 10.25005/2074-0581-2018-20-4-00.00

[187] Shah S, Pocard M, Mirshahi M, Targeting the differentiation of gastric cancer cells (KATO-III) downregulates epithelial-mesenchymal and cancer stem cell markers, Oncol Rep. 2019 Aug;42(2):670-678. doi: 10.3892/or.2019.7198. Epub 2019 Jun 12.

[188] Shah S, Aldybiat M, Ullah M, Kaci R, Alassaf A, Evno C, Pocard M, Mirshahi M. Fibrin deposit on the peritoneal surface serve as a niche for cancer expansion in carcinomatosis patients, Oncotarget, 21; 11, November 2019, Pages 1091-1101.

[189] Baitukha A, Al-Dybiat I, Valinataj-Omran A, Pulpytel J, Pocard M, Mirshahi M, Arefi-Khonsari F.

Optimization of a low pressure plasma process for fabrication of a Drug Delivery System (DDS) for cancer treatment. , Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110089. doi: 10.1016/j.msec.2019.110089. Epub 2019 Aug 15.

[190] Sharofova MU, Aldibiat I, Saidov Kh.B ,.Sagdieva Sh.S, Khakimov FR. , Rahimi F.K, Mirshahi M. Plastic biodegradation by wax moth larvae of galleria mellonella from darvaz Proceeding of Tajikistan Academy of Science, 2019, V 62, №3-4, 221-228.

[191] Ulla M., Meziyani S., Shah S., Pimpie C., Kaci R., Pocard M., Mirshahi M. Differentiation therapy helps cancer cell evade immunity via up regulation of HLA-G and PD-L1. Oncol Rep. 2020 Jun;43(6):1797-1804. doi: 10.3892/or.2020.7572.

[192] Al Dybiat I, Baitukha A, Pimpie C, Kaci R, Pocard M, Arefi Khonsari F, Mirshahi M, Multi-nanolayer drug delivery using radiofrequency plasma technology. BMC Cancer. 2020 Jun 17;20(1):565. doi: 10.1186/s12885-020-06989-w.

[193] Al Dybiat I, Mirshahi S, Belalou M, Abdelhamid D, Shah S, Ullah M, Soria J, Pocard M, Mirshahi M , Injured tissues favor cancer cell implantation via fibrin deposits on scar zones. Neoplasia. 2020 Dec;22(12):809-819. doi: 10.1016/j.neo.2020.09.006.

[194] Ullah M, Aoudjeghout W, Pimpie C, Pocard M, Mirshahi M Mitosis in Cancer Cell Increases Immune Resistance via High Expression of HLA-G and PD-L1. .Cancers (Basel). 2020 Sep 18;12(9):2661. doi: 10.3390/cancers12092661.

**********

CONTRIBUTIONS DANS DES LIVRES


[1] Boucheix C., Mirshahi M., Soria J., Soria C., Perrot J.Y., Bernadou A., Rosenfeld C. Monoclonal antibodies for domains which are differentially expressed in fibrinogen, in fibrinogen degradation products or in fibrin degradation products.

Protides of the Biological Fluids, 1982, 30, 399-402.

[2] Soria J., Soria C., Boucheix C., Mirshahi M., Perrot J.Y., Bernadou A., Samama M. Immunochemical differentiation of fibrinogen, fragment D or E and cross-linked fibrin degradation products using monoclonal antibodies.

In: Fibrinogen: Structure, Functional Aspects, Metabolism, Walter de Gruyter, 1983, 2, 227-233.

[3] Soria J., Soria C., Boucheix C., Mirshahi M., Perrot J.Y., Bernadou A., Samama M., Rosenfeld C. Monoclonal antibodies which react differentially with fibrinogen degradation products or with cross linked fibrin split products.

Ann. N.Y. Acad. Sci., 1983, 408, 665-666.

[4] Soria J., Soria C., Dunn F., Deguchi K., Mirshahi M., Lijnen R., Nieuwenhuisen W., Haverkate F., Samama M., Caen J.P. Study of the interaction between plasminogen and fibrinogen degradation products using immuno-enzymological assay.

"Fibrinogen structural variants and Interactions" Eds. A. Henschen, B. Hessel, J. McDonag, T. Saldeen (W. de Gruyter, Berlin, New York), 1985, 3, 313-322.

[5] Mirshahi M., Soria J., Soria C., Perrot J.Y., Bernadou A., Boucheix C. Fibrinogen degradation products determination using a monoclonal anti-D neo antibody. Advantages in clinical investigation.

Proc. 4th Internat. Conf. on Fibrinogen, Lane D.A. et al., Eds, Walter de Gruyter, 1985.

[6] Soria C., Soria J., Mirshahi M., Boucheix C., Thomaidis A., Samama M., Caen J.P. Conformational change of fibrinogen subsequent to its binding to platelets.

Proc. 4th Internat. Conf. on Fibrinogen, Lane D.A. et al., Eds, Walter de Gruyter, 1985.

[7] Enouf J., Boucheix C., Bredoux R., Le Peuch C., Soria C., Mirshahi M., Levy Toledano S. Differentiation between two 23 kd-24 kd proteins involved in calcium fluxes using the monoclonal antibody ALB6.

Monoclonal antibodies and human blood platelets, Ed. J.C. Mc Gregor, Elsevier, Amsterdam,1986, 201-210.

[8] Soria J., Soria C., Mirshahi M.C., Ma Xi, Mirshahi M., Samama M., Caen J.P. Specific identification and determination of fibrin degradation products in patients with acute myocardial infarction under tissue plasminogen activator therapy. Pathophysiologic processes of fibrin formation and dissolution during the time course of thrombolytic therapy.

Fibrinogen and its Derivatives, Muller-Berghaus G. et al., Eds, Elvevier, Amsterdam, 1986, 301-306.

[9] Soria C., Soria J., Mirshahi, M.C., Mirshahi M., Faivre R., Neuhart E., Kieffer Y., Bassans J.P., Maurat J.P., Caen J.P. Plasma fibrin degradation products determination: a non invasive technique to follow the evolution of deep vein thrombosis. Evolution under standard heparin and low molecular weight heparin (CY222).

Fibrinogen and its Derivatives, Muller-Berghaus G. et al., Eds, Elsevier, Amsterdam, 1986, 307-311.

[10] Soria J., Soria C., Mirshahi M.C., Mirshahi M., Pujade E., Dunica S., Faivre R., Boucheix C., Perrot J.Y., Bernadou A., Samama M., Caen J.P. A review of clinical experience with a monoclonal antibody to fibrin degradation products.

Fibrinogen 2, Lowe G.D.O. et al., Eds, Elsevier, Amsterdam, 1987.

[11] Soria C., Soria J., Mirshahi M.C., Mirshahi M., Bertrand O., Caen J.P. The relationship between clot structure and fibrinolysis.

Fibrinogen 2, Elsevier, Amsterdam, 1987.

[12] Mirshahi M., Mirshahi, M. C., Soria J., Bertrand O., Mirshahi, S., Lu H., Cochet S., Boucheix C., Bernadou A., Caen J.P., Soria C. Monoclonal antibodies reacting with fibrinogen derivatives inhibit the binding of tissue plasminogen activator to fragment D.

Fibrinogen 3. Biochemistry, Biological Functions, Gene Regulation and Expression., M.W. Mosesson et al., Eds, Elsevier, Amsterdam, 1988, 147-152.

[13] de Kozak Y., Mirshahi M., Boucheix C., Faure J.P. Immunization with anti-S-antigen monoclonal antibodies prevents experimental autoimmune uveoretinitis (EAU) in rats.

Immunology and Immunopathology of the Eye. Secchi A.G., Fregona I.A., Eds., Modern Trends in Masson, Milano, 1989, 26-30.

[14] Mirshahi M., de Kozak Y., Faure J.P., Brisson P., Falcon J., Collin J.P. Influence of light on S-antigen localization in rods and cones and immunopathogenicity in rats.

Modern Trends in Immunology and Immunopathology of the Eye, Secchi A.G., Fregona I.A.,Eds., Masson, Milano, 1989, 45-49.

[15] de Kozak Y., Mirshahi M., Boucheix C., Faure J.P. Anti-idiotypic antibodies (internal image) modulate autoimmune uveoretinitis induced by S-antigen.

Ocular Immunology Today M. Usui M. , Ohno S., Aoki K., Eds., Excerpta Medica, Amsterdam, 1990,425-429.

[16] Mirshahi M., de Kozak Y., Gregerson D.S., Stiemer R., Boucheix C., Faure J.P. Genetic susceptibility of rat strains to induction of EAU in relation with the immune response to a particular epitope of S-antigen.

Ocular Immunology Today M. Usui M. , Ohno S., Aoki K., Eds., Excerpta Medica, Amsterdam, 1990, 95-98.

[17] Mirshahi M., Mirshahi S.S., Mirshahi, M.C., Soria C., Bertrand O., Soria C. A monoclonal antibody to fibrinogen inhibiting fibrin polymerization.

Fibrinogen 4. Current Basic and Clinical Aspects, Matsuda M. et al., Eds., Elsevier, Amsterdam, 1990, 49-54.

[18] Soria J., Mirshahi M.C., Mirshahi S.S., Mirshahi M., Pujade-Lauraine E., Bernadou A., Soria C. Soluble fibrin in plasma using a specific fibrin-monoclonal antibody directed against the N terminal part of the beta chain.

Fibrinogen 4. Current Basic and Clinical Aspects, Matsuda M. et al., Eds., Elsevier, Amsterdam, 1990, 187-194.

[19] de Kozak Y., Mirshahi M., Stiemer R., Faure J.P. La réponse anticorps contre un motif commun présent dans l’Antigène S et le tumor necrosis factor alpha inhibe l’uvéo-rétinite auto-immune expérimentale.

Neurobiologie de la Rétine. Séminaires Ophtalmologiques Ipsen, vol. 4, Christen F., Doly M., Droy-Lefaix MT, Eds., Springer-Verlag, Heidelberg, 1992

[20] Mirshahi A., Nato A., Lavergne D., Ducreux G., Faure J.P., Mirshahi M. Chloroplastic membrane-bound arrestin-like immunoreactive proteins in tobacco and Chlamydomonas cells. Structure and Functions of Retinal Proteins,. Rigaud J. L, Ed., INSERM-John Libbey Eurotext, Paris, 1992, 351-354.

[21] Razaghi A., Borgese F., Fiévet B., Motais R., Nato A., OliverJ.,Vandewalle A., Mirshahi M., Faure J.P. Proteins related to retinal S-antigen (arrestin) in non photosensitive cells. Structure and Functions of Retinal Proteins, J. L. Rigaud, Ed., INSERM-John Libbey Eurotext, Paris, 1992, 355-358.

[22] Mirshahi A., , J.M. Cavalcante Alves, G. Tichtinsky, Y. Henry, D. Lavergne, G. Ducreux, J.-P. Faure, M. Mirshahi and A. Nato. Plant signal transduction pathways: Arrestin-like proteins are involved in wheat somatic embryogenesis process .

Plant Sciences, 1994, p 76; Y. de Kouchkovsky and F. Larher, eds. SFPV- Université de Rennes

[23] Nato A., Mirshahi A., Cavalacante Alves J.M., Lavergne D., Ducreux G., Mirshahi M., Faure J.P., DeBuyser J., Tichtinsky G., Kreis M., Henry Y. Are arrestin -like proteins involved in plant signal transduction pathways)

Current issues in Plant Molecular and Cellular Biology; 1995 Terzi M.et al (eds) Kluwer Academic Publishers, Netherlands.

[24] Mirshahi M., Mirshahi S., Nicolas C., Mishal Z., Dagonet F., Hecquet C., Lounes K.C., d'Hermies F., Pouliquen Y., Agarwal M.K. Steroid Hormone action on the amilorid-sensitive sodium channel(ASSC)

Advance In Comparative Endocrinology,S. Kawashima and S. Kikuyama Eds. 1997, pp1273-1277, Monduzzi Ed. Bologna, Italy

[25] Mirshahi M., Nuraliev Y., The elements of avestian medicine in tajik traditional medicin. Aryan Civilization in the context of Euroasian culture. Mohemmadjkhojeev Ed., 2006, 525-543 Donish, Dusghanbé Tadjikistan.

[26] Nuraliav Y., Mirshahi M., Periodization of the History of Avestian medicin, (2006), Aryan Civilization in the context of Euroasian culture. A. Mohemmadjkhojeev, Ed. , 2006, pp 525-543, Donish, Dusghanbé Tadjikistan.

[27] Mirshahi P., Bertauth A., Ducros E., Soria J., Agarwal M. K., Mirshahi M., Pleiotropic gene modulation by aldosterone in the human endothelia cells.

Current advance in heart disease, Asher Kimchi Ed. Medimond, Bologna, Italy, 2008.

[28] Mirshahi M.. Aldosterone signaning modifies endothelial cell volme in vitro.

Current advance in heart disease, Asher Kimchi Ed. Medimond, Bologna, Italy, 2008.

[29] Kurbonov U., Dustov A., Barotov A., Khidirov M., Rahimov z., Navjuvonov N., Irgasheva J., Didary A., Muminjonov S., Mirojov G., Gulmuradov T., Mirshahi M. Intracoronary infusion of autologous CD133+ cells in myocardial infarction and tracing by Tc-99m MIBI scintigraphy of the heart areas involved in cell homing. Current advance in heart disease, Asher Kimchi Ed. Medimond, Bologna, Italy 2014.

[30] Pulpyte J , Bhatt S, Lis R , Mirshahi M, Arefi-Khonsari F

Poly (ε-caprolactone)-Poly (ethylene glycol) Copolymer coatings Developed by Low Pressure Inductively Excited PECVD for Tailored Cell Adhesion

International Symposium on Plasma Chemistry 20th, Philadelphia, USA; 07/2011

[31] Kurbonov U, Dustov A, BarotoV A, Khidirov M, RahimovZ, Navjuvonov V, Irgasheva J, Didary A, Muminjonov S, , Mirojov G , Gulmuradov T, Mirshah M. Intracoronary Infusion of Autologous CD133(+) Cells in Myocardial Infarction and Tracing by Tc99m MIBI Scintigraphy of the Heart Areas Involved in Cell Homing. Word Biomedical Frontiers http://biomedfrontiers.org/stem-cells-2013-11-11/

[32] Kurbon U, Dodariyon H , Davlatov1 A, Janobilova1 S, Mirshahi M. New Advances on the Surgical Treatment of Bronchial Asthma, pp 2-26, Avid Science Monograph Series, 2016.

[33] Valinetaj O A., Baituka A., Fakuri H., Arefi-Khonssari F., Mirshahi M., Sohbatzadeh F. Ovarian cancer cell treatmentusing transporting atmospheric pressure Plasma jet. 22 nd nternational symposium on plasma chemistry , Belgium, 2015. (proceeding)

[34] Iman Al dybiat , Massoud. Mirshahi, Damaged tissues promote the implantation of cancer cells through deposits of fibrin on scarred areas , International Symposium on Innoative development of science, Dushanbe Tajikistan ,10 Dec. 2020, (proceeding)

[35] AL Dybiat I, Arefi-Khonsari F & Massoud Mirshahi, Biodegradable nano film generated by plasma stream, A new window for cancer therapy , International Symposium on Innoative development of science, Dushanbe Tajikistan, 10 Dec. 2020 . (Proceeding)

[36] Matti Ullah, Massoud Mirshahi Cancer cells during their division resist the immune system via the secretion of HLA-G and PDL-1, International Symposium on Innoative development of science, Dushanbe Tajikistan, 10 Dec. 2020. (proceeding)


**********

COMMUNICATIONS DANS DES CONGRES

[1] Faure J.P., Mirshahi M., Dorey C., Thillaye B., Cozette J., Tuyen V.V., de Kozak Y., Perrot J.Y., Boucheix C. Anticorps monoclonaux contre l'Antigène S de la rétine.

Soc. Fr. Immunol., Institut Pasteur, 1982.

[2] Faure J.P., Mirshahi M., Thillaye B., Dorey C., Tuyen V.V., Soria U., de Kozak Y., Boucheix C. Monoclonal antibodies against the retinal S-antigen.

Assoc. Eye Res. 23rd Meeting, Aachen, 1982.

[3] Boucheix C., Perrot J.Y. Mirshahi M., Fournier N., Billard M., Bernadou A., Rosenfeld C. Monoclonal antibodies against acute lymphoblastic leukemia differentiation antigens.

First Internat. Workshop on human Leucocyte Differentiation Antigens. Paris, 1983.

[4] Dorey C., Mirshahi M., Brandao E., de Kozak Y., Faure J.P. Properties of human retinal S-antigen.

Assoc. for Eye Res., 24th Meeting, Vienne, 1983.

[5] Mirshahi M., Soria J., Soria C., Boucheix C., Perrot J.Y., Nieuwenhuisen W., Haverkate F., Bernadou A., Samama M., Rosenfeld C. Characterisation of differently expressed epitopes in fibrinogen, fibrinogen degradation products and fibrin degradation products using monoclonal antibodies.

IX International Congress on Thrombosis and Haemostasis, Stockholm, 1983.

[6] Altério J., Dorey C., Mirshahi M., Faure J.P., Barritault D. In vitro translation of S-antigen by bovine retina mRNA.

6th Intern. Congress of Eye Research, Alicante, 1984.

[7] Faure J.P., Mirshahi M. Application of monoclonal antibodies to immunofluorescence localization and interspecies distribution of retinal S-antigen.

Conférence, National Institute of Health, Bethesda, 1984.

[8] de Kozak Y., Mirshahi M., Utsumi T., Fournier N., Boucheix C., Faure J.P. Inhibition of experimental autoimmune uveoretinitis by monoclonal antibodies against S-antigen.

Assoc. Res Vision Ophthalmol., Sarasota, USA, 1984.

[9] Mirshahi M., Boucheix C., Collenot G., Thillaye B., Dorey C., Faure J.P. An immunofluorescent study of the taxonomic distribution of retinal S-antigen using monoclonal antibodies.

Assoc. Res Vision Ophthalmol., Sarasota, USA, 1984.

[10] Soria C., Soria J., Dunn P., Deguchi K., Mirshahi M., Lijnen R., Samama M., Caen, J.P. Comparison between the potentiating effect induced by fibrin (ogen) derivatives on plasminogen activation induced by either streptokinase or tissue plasminogen activator.

Seventh Internat. Congress on Fibrinolysis, Venise, 1984.

[11] Soria C., Soria J., Dunn P., Deguchi K., Mirshahi M., Samama M, Caen J.P. Potentiating effect of fibrin degradation products in the amidolytic activity of plasminogen-SK complex. Influence of the substrate used.

8th Internat. Congress on Thrombosis, Istanbul, 1984.

[12] Soria J., Soria C., Mirshahi M., Desvignes P., Dunn F., Bonnet P. Homozugous dysfibrinogen variant characterized by an absence of reactivity of the polymerizing site "a" located in the gamma chain: fibrinogen Ales.

8th Internat. Congress on Thrombosis, Istanbul, 1984.

[13] Soria C., Soria J., Mirshahi M., Desvignes P., Dunn F., Boucheix C., Bonnet P., Bernadou A . Study of interaction between fragment D, and Des-A fibrin monomer. Clinical and pharmacological application.

Seventh Internat. Congress on Fibrinolysis, Venise, 1984.

[14] de Kozak Y., Mirshahi M., Boucheix C., Faure J.P. Serological investigations on experimental autoimmune uveoretinitis suppressed by S-antigen-specific monoclonal antibodies.

Assoc. for Eye Res., 26th Meeting, Leysin, 1985.

[15] de Kozak Y., Mirshahi M., Boucheix C., Faure J.P. Suppression de l'uvéo-rétinite auto-immune expérimentale par injection d'anticorps monoclonaux spécifiques de l'auto-Antigène S : étude sérologique.

Journée de la Recherche, UER Broussais-Hôtel-Dieu, Paris, 1985.

[16] Enouf J., Bredoux R., Boucheix C., Mirshahi M., Soria C., Levy-Toledano S. Regulation of platelet calcium flux by a monoclonal antibody.

X International Congress on Thrombosis and Haemostasis, San Diego, 1985.

[17] Falcon J., Mirshahi M., Brisson P., Faure J.P., Guerlotté B., Collin J.P. S-antigen immunoreactivity in retinal rods and cones and pineal photosensitive cells.

Fifth Europ. Winter Conf. on Brain Res., Vars-les-Claux, 1985.

[18] Mirshahi M., Falcon J., Brisson P., Guerlotté J., Faure J.P., Collin J.P. S-antigen immunoreactivity in pineal organ of various vertebrates.

Assoc. for Eye Res., 26 th Meeting, Leysin, 1985.

[19] Mirshahi M., Soria J., Soria C., Boucheix C. Determination of fibrin(ogen) degradation products directly in plasma using a monoclonal anti D-néo antibody. Clinical applications.

International Congress on Fibrinogen, fibrin and fibrinolysis. Londres 1985.

[20] Soria C., Soria J., Mirshahi M., Boucheix C., Thomaidis A., Samama M., Caen J.P. Platelet-associated fibrinogen. Conformational change in fibrinogen.

International Congress on Fibrinogen, fibrin and fibrinolysis. Londres, 1985.

[21] Soria J., Soria C., Bertrand O., Mirshahi M., Dunn F., Desvignes P., Bonnet P., Samama M., Caen J.P. Role of fibrin polymerization in the potentiating effect of fibrin on tpA-induced plasminogen activation.

International Congress on Fibrinogen, fibrin and fibrinolysis. Londres, 1985.

[22] de Kozak Y., Mirshahi M., Boucheix C., Faure J.P. Immunization with anti-S-antigen monoclonal antibodies prevents experimental autoimmune uveoretinitis (EAU) in rats.

4th Internat. Symp.on the Immunology andImmunopathology of the Eye, Padoue, 1986.

[23] Mirshahi M., Faure J.P., Brisson P., Falcon J., Guerlotté J., Voisin P., Collin J.P. Photorécepteurs rétiniens et transducteurs de l'organe pinéal: mise en évidence de l'Antigène S, molécule impliquée dans la phototransduction.

Colloque National des Neurosciences, Bordeaux, 1986.

[24] Mirshahi M., de Kozak Y., Faure J.P., Brisson P., Falcon J., Collin J.P. Influence of light on S-antigen localization in rods and cones and immunopathogenicity in rats.

4th Internat. Symp. on Immunology and Immunopathology of the Eye, Padoue, 1986.

[25] Mirshahi M.C., Soria J., Soria C., Bertrand O., Mirshahi M., Basdevant A. Fibrinogen glycosylation and its consequences on thrombolysis.

Fibrinogen Workshop, Giessen, 1986.

[26] Mirshahi M.C.,Soria J.,Soria C., Bertrand O., Mirshahi M., Basdevant A. Fibrinogen glycosylation and its consequences on thrombolysis.

IX World Congress of Phlebology, Satellite Symposium on Fibrinolysis, Osaka, 1986.

[27] Mirshahi M.C.,Soria J.,Soria C., Bertrand O., Mirshahi M., Basdevant A. Fibrinogen glycosylation and its consequences on thrombolysis.

IX World Congress of the International Union of Phlebology, Kyoto, 1986.

[28] Plouët J., Dorey C., Mirshahi M., Lorans G., Faure J.P. Protéines communes aux photorécepteurs rétiniens et à l'épiphyse.

Colloque National des Neurosciences, Bordeaux, 1986.

[29] Soria C., Soria J., Mirshahi M.C., Mirshahi M., Dunnica S., Boucheix C., Caen J.P. Importance of fibrinolysis in the evolution of acute coronary syndrome.

IX World Congress of Phlebology, Satellite Symposium on Fibrinolysis, Osaka, 1986.

[30] Soria J., Soria C., Ma Xi , Mirshahi M. C., Mirshahi M., Nguyen G., Samama M., Caen J. A new technique for specific identification of fibrinogen and fibrin derivatives in plasma; clinical application.

Fibrinogen Workshop, Giessen, 1986.

[31] Soria J., Soria C., Mirshahi M. C., Mirshahi M., Caen J. The relation between clot structure and fibrinolysis.

IX World congress of the international union of phlebology. Satellte symposium on fibrinolysis. Hamamatsu, 1986

[32] Soria J., Soria C., Mirshahi M. C., Mirshahi M., Dunnica S., Boucheix C.,Bernadou A. Importance of fibrinolysis in the evolution of acute coronary syndrome.

IX World Congress of the International Union of Phlebology, Kyoto, 1986.

[33] Soria J., Soria C., Mirshahi M. C., Mirshahi M., Faivre R., Neuhart E., Ma Xi , Kieffer Y., Bassand J.P., Maurat J.P., Caen J. Plasma fibrin degradation products. A non invasive technique to follow the evolution of deep vein thrombosis. Evolution under standard heparin or low molecular weight heparin.

Fibrinogen Workshop, Giessen, 1986.

[34] Soria J., Soria C., Mirshahi M. C., Mirshahi M., Pujade L E., Dunnica S., Boucheix C., Bernadou A. Assay of fibrin degradation products in plasma using a monoclonal antibody ; interest in clinical investigation.

IX World Congress of the International Union of Phlebology. Satellte symposium on fibrinolysis, Hamamatsu, 1986.

[35] de Kozak Y., Mirshahi M., Boucheix C., de Veyrac B., Faure J.P. Adoptive transfer of EAU suppression by cells from rats immunized with anti-S-antigen monoclonal antibodies.

Assoc. for Eye Res., 28th Meeting, Louvain, 1987.

[36] Lu He, Mirshahi M., Soria J., Soria C., Mirshahi M., Thomaidis A., Boucheix C., Caen J.P. Importance of conformational changes of fibrinogen induced by surface adsorption.

XI International Congress on Thrombosis and Haemostasis. Bruxelles,1987.

[37] Mirshahi M.C., Soria J., Soria C., Ma Xi, Mirshahi M., Samama M., Caen J.P. Dissociation between level and recanalization in patients undergoing thrombolytique therapy for mycardial infarction.

XI International Congress on Thrombosis and Haemostasis. Bruxelles,1987.

[38] Mirshahi M., Hamm M., de Kozak Y., Thillaye B., Faure J.P. Light-induced changes in alpha-transducin and S-antigen localization in retinal photoreceptors.

Assoc. for Eye Res., 28th Meeting, Louvain, 1987.

[39] Mirshahi M., Soria J., Soria C., Mirshahi S., Perrot J.Y., Boucheix C., Bernadou A. Modification of fibrine polymerization induced by monoclonal antibodies against fragment D domain of fibrin/ogen degradation products.

XI International Congress on Thrombosis and Haemostasis. Bruxelles,1987.

[40] Mirshahi M., Stiemer R., Bertrand O., Lu He, de Kozak Y., Faure J.P. Phylogenetically conserved epitopes are located in the amino-terminal region of retinal S-antigen.

Assoc. for Eye Res., 28th Meeting, Louvain, 1987.

[41] Soria C., Mirshahi M.C., Soria J., Mirshahi M., Fevre R., Neuhart D., Kieffer Y., Maurat J.P., Caen J.P.Monitoring influence of heparin regimen.

XI International Congress on Thrombosis and Haemostasis. Bruxelles,1987.

[42] Soria J., Soria C., Mirshahi M.C., Mirshahi M., Faivre R., Neuhart E., Kieffer Y., Maurat J.P., Caen J.P. Fibrinolyse et polysaccharides sulfates.

Soc. Fr. Thérapeutique et Pharm. Clinique : les héparines de bas poids moléculaires: aspects pharmacologiques et thérapeutiques, Caen 1987.

[43] Soria J., Soria C., Mirshahi M.C., Mirshahi S., Mirshahi M., Pujade E., Boucheix C., Samama M., Bernadou A., Caen J.P. DDE complex determination as a specific marker for fibrinolysis.

XI International Congress on Thrombosis and Haemostasis. Bruxelles,1987.

[44] Stiemer R., Gierschik P., de Kozak Y., Mirshahi M., Faure J.P. Characterization of crossreactions between S-antigen (48 kDa protein of bovine ROS) and different G-proteins.

Assoc. for Eye Res., 28th Meeting, Louvain, 1987.

[45] Tuyen V.V., de Kozak Y., Mirshahi M., Faure J.P. Anti-idiotypic antibodies in the rat experimental autoimmune uveoretinitis induced by retinal S-antigen.

Assoc. for Eye Res., 28th Meeting, Louvain, 1987.

[46] de Kozak Y., Mirshahi M., Boucheix C., Faure J.P. Modulation of experimental autoimmune uveoretinitis by adoptive transfer of cells from rats immunized with anti-S-antigen monoclonal antibodies.

Soc. Fr; Immunol., Paris, 1988.

[47] de Kozak Y., Mirshahi M., Boucheix C., Faure J.P. Experimental autoimmune uveoretinitis: idiotypic anti-idiotypic interaction and disease suppression.

Colloque Immuno-Intervention dans les Maladies Auto-immunes, Paris, 1988.

[48] Mirshahi M., Hamm H., de Kozak Y., Thillaye B., Faure J.P. The alpha subunit of transducin disappears from photoreceptor cells at an early stage of light-induced retinal degeneration.

Colloque Soc. Fr. Microscopie Electronique, Inst. Pasteur, Paris, 1988.

[49] Mirshahi M., de Kozak Y., Thillaye B., Creed C., Faure J.P. Experimental autoimmune pinealitis.

Soc. Fr. Immunol., Paris, 1988.

[50] Mirshahi M., Mirshahi M.C., Soria J., Bertrand O., Mirshahi S., Hu H., Boucheix C., Bernadou A., Caen J.P., Soria C. A monoclonal antibody (X7E10) reacting with fibrinogen A alpha 105-196 inhibits the binding of tissue plasminogen to fragment D.

International Fibrinogen Workshop, Milwaukee, 1988.

[51] de Kozak, Mirshahi M., Boucheix C., Faure J.P. Suppression of experimental autoimmune uveoretinitis by administraztion of an anti-idiotypic antibody to a monoclonal antibody directed at S-antigen.

7th. Intern.Congress of Immunology, Berlin, 1989.

[52] de Kozak Y., Mirshahi M., Boucheix C., Faure J.P. Suppressive effect of an anti-idiotypic antibody directed against the monoclonal antibody S2D2 on induction of EAU by S-antigen in rats.

Assoc. for Eye Res., 30th Meeting, La Grande-Motte, 1989.

[53] Faure J.P., Mirshahi M. S-antigen in non ocular tissues.Int. Symposium on Recent Developments in the Immunopathology of Intraocular Inflammation, Amsterdam, 1989.

[54] Mirshahi M., de Kozak Y., Stiemer R., Boucheix C., Gregerson D., Bertrand O., Faure J.P. The susceptibility of rat strains to S-antigen-induced experimental autoimmune uveorretinitis is related to their non response to a given epitope of S-antigen.

7th Int. Congress of Immunology, Berlin, 1989.

[55] Mirshahi M., Mirshahi S., Soria C., Soria J., Thomaidis A., Pouliquen Y., Faure J.P. Corneal plasminogen activators.

Assoc. for Eye Res., 30th Meeting, La Grande Motte, 1989.

[56] Mirshahi M., Mirshahi S., Soria C., Soria J., Thomaidis A., Pouliquen Y., Faure J.P. Human corneal plasminogen activators. Characterization, localization and modulation.

12 th Congress of the International Society on Thrombosis and Haemostasis, Tokyo, 1989.

[57] Mirshahi M., Stiemer S., Boucheix C., Gregerson D. S., Bertrand O., Razaghi A., Zech J.C., de Kozak Y., Faure J.P. Properties of monoclonal antibodies that recognize different regions of the S-antigen molecule.

Symposium on Recent Developments in the Immunopathology of Intraocular Inflammation, Amsterdam, 1989.

[58] Neuhart E., Faivre R., Soria C., Soria J., Kieffer Y., Mirshahi M., Bassand J.P., Caen J.P., Maurat J.P. Do heparins act as fibrinolysis activators?

12 th Congress of the International Society on Thrombosis and Haemostasis, Tokyo, 1989.

[59] Neuhart E., Faivre R., Soria C., Soria J., Mirshahi M., Bassand J.P., Caen J.P., Maurat J.P. Fibrinolytic activity: pronostic values in venous thrombo-embolism.

12 th Congress of the International Society on Thrombosis and Haemostasis, Tokyo, 1989.

[60] Oliver J., Herbuté S., Gabrion J., Mirshahi M., Boissin-Agasse L., Roch G., Brisson P., Collin J.P., Faure J.P. Influence de l'obscurité sur la distribution de l'antigène S et sur la différenciation des microvillosités apicales dans les plexus choroides de la caille.

Soc. Française des Neurosciences, 3e Colloque National, Montpellier, 1989.

[61] Stiemer R., Gausepohl H., Mirshahi M., de Kozak Y., Kraft M., Faure J.P., Frank R. Localization of an immunopathologically important epitope in the bovine retinal S-antigen by the pepscan method.

1st Intern.Workshop "Molecular and Cell Biology of Autoantibodies and Autoimmunity", Heidelberg, 1989.

[62] Stiemer R., Gausepohl H., Mirshahi M., de Kozak Y., Kraft M., Faure J.P., Frank R. Identification and characterization of an immunomodulatory stable epitope in the N-terminal region of S-antigen.

Symposium on Recent Developments in the Immunopathology of Intraocular Inflammation, Amsterdam, 1989.

[63] Stiemer R., Mirshahi M., Gausepohl H., Faure J.P., Frank R. Characterization of monoclonal antibodies directed against the C-terminus of S-antigen by the Pepscan method. Symposium on Recent Developments in the Immunopathology of Intraocular Inflammation, Amsterdam, 1989.

[64] Thillaye B., Jobin D., Le Hoang P., Zech C., Mirshahi M., Sainte-Laudy J., Faure J.P. Immune response to retinal antigens in patients with uveitis or retinal diseases.

Europ. Club Ocular Immunology, La Grande-Motte, 1989.

[65] Zech J.C., Mirshahi M., Faure J.P. Production and characterization of two monoclonal antibodies against degradation products of retinal S-antigen.

Assoc. for Eye Res., 30th Meeting, La Grande Motte, 1989.

[66] de Kozak Y., Mirshahi M., Bellon B., Faure J.P. Role of antibodies in the production and the suppression of experimental autoimmune uveoretinitis.

9th International Congress of Eye Research, Helsinki , 1990.

[67] de Kozak Y., Mirshahi M., Boucheix C., Faure J.P. Anti-idiotypic antibodies (internal image) modulate autoimmune uveoretinitis induced by S-antigen.

5th Int. Symposium on Immunology and Immunopathology of the Eye, Tokyo, 1990.

[68] de Kozak Y., Mirshahi M., Boucheix C., Faure J.P. Modulation of S-antigen induced experimental autoimmune uveoretinitis by anti-idiotypic S2D2 antibody (internal image) or by a synthetic peptide recognized by the monoclonal antibody S2D2.

Joint Meeting, Société Française d'Immunologie, Nederlandse Vereniging voor Immunologie, Paris,1990.

[69] Mirshahi M., Borgese F., Razaghi A., Scheuring U., Motais R., Faure J.P. S-antigen-like protein in non photosensitive cells.

5th Int. Symposium on Immunology and Immunopathology of the Eye, Tokyo, 1990.

[70] Mirshahi M., de Kozak Y., Gregerson D.S., Stiemer R., Boucheix C., Faure J.P. Susceptibility of various rat strains to induction of EAU in relation with the immune response to definite epitopes of S-antigen.

5th Int. Symposium on Immunology and Immunopathology of the Eye, Tokyo, 1990.

[71] Mirshahi M., de Kozak Y., Tarraf M., Razaghi A., Faure J.P.Early disappearance of alpha -transducine in light-induced photoreceptor degeneration in albino rats.

International Retinitis Pigmentosa Association, Dublin , 1990.

[72] Mirshahi M., Mirshahi S., Bureau J., Soria C., Lorans G., Soria J., Faure J.P., Pouliquen Y. Regulation by growth factors of the secretion of plasminogen activators and plasminogen activator inhibitors by normal and dystrophic corneal fibroblasts.

9th International Congress of Eye Research, Helsinki, 1990.

[73] Mirshahi M., Mirshahi S., Soria C., Lorans G., Bureau J.,Soria J. ,Pouliquen Y. Anomaly of extracellular matrix associated with defective release of plasminogen activator by corneal fibroblasts in Schnyder dystrophy.

INSERM, Conférence Philippe Laudat, 1990.

[74] Mirshahi M., Mirshahi S., Soria J., Perrot J.Y., Boucheix C., Soria C. Phylogeny of fibrinogen molecule using monoclonal antibodies: evolution of some functional domains.

10th Fibrinogen Workshop, Rouen, 1990.

[75]Mirshahi M., Razaghi A., Borgese F., Scheuring U., Motais R., Faure J.P. Immunochemical evidence of arrestin-like protein in non photosensitive cells.

9th International Congress of Eye Research, Helsinki , 1990.

[76] Mirshahi M., Razaghi A., Stiemer R. , Faure J.P. Arrestin-like protein in cardiac muscle.

American heart association , Dallas, USA, 1990.

[77] Mirshahi M., Tarraf A., Mohay J., de Kozak Y., Faure J.P. A defect in intracellular protein transport occurs in photoreceptors at an early stage of photoreceptor degeneration in the RCS rat.

International Retinitis Pigmentosa Association, Dublin , 1990.

[78] Mohay J., Resende R., Mirshahi M., de Kozak Y., Thillaye B., Faure JP. S-antigen in the developing normal and RCS retina : a monoclonal antibody study.

Assoc. for Eye Res., 31st Meeting, Bad Honnef, Bonn, 1990.

[79] Razaghi A., Mirshahi M., de Kozak Y., Dorey C., Geulut-Chassaing, C., Voisin P., Faure J.P. Properties of S-antigen (arrestin) from bovine pineal gland.

5th Colloquium of the Europ. Pineal Study Group, Guildford, 1990.

[80] Claudy A.L., Mirshahi M., Soria C., Soria J. Identification de facteurs de la coagulation et de facteurs d'activation cellulaire dans les ulcères veineux.

XIII Congrès Annuel de la Recherche Dermatologique, Marseille, 1991.

[81] de Kozak Y., Mirshahi M., de Smet M., Gery I., Faure J.P. Immunoregulatory properties of the 40-50 amino acid sequence of S-antigen in S-antigen-induced EAU.

Assoc. for Eye Res., 32nd Meeting, Aarhus, 1991.

[82] de Kozak Y., Mirshahi M., Stiemer R., Boucheix C., Faure J.P. Experimental autoimmune uveoretinitis : long lasting protection induced by injection of anti-S-Ag monoclonal antibody S2D2.

Soc. Fr. Immunol., Paris,1991.

[83] de Kozak Y., Mirshahi M., Stiemer R., Boucheix C., Faure J.P. Idiotypic vaccination of experimental autoimmune uveoretinitis.

2nd Congress on Immunointervention in Autoimmune Diseases, Paris, 1991.

[84] de Kozak Y., Stiemer R. H., Mirshahi M., Frank R. W., de Smet M., Faure J. P. Humoral immune response against the S-antigen/TNFa common epitope in rat EAU suppressed by the monoclonal antibody S2D2.

2nd International Symposium on Recent Developments in the Immunopathology of Intraocular Inflammation, Aberdeen, 1991.

[85] Keller N., Mirshahi M., Durand J., Pouliquen Y. Presence of functional visual cells in the proteus degenerate retina.

Association for Eye Research, 32nd Meeting, Aarhus, 1991.

[86] Mirshahi M., Claudy A., Soria C., Soria J. Deposition of fibrin and tissue necrosing factor in venous ulceration: Pathogeny of ulceration process.

XIII Congress International Society on Thrombosis and Haemostasis, Amsterdam, 1991.

[87] Mirshahi M., Mirshahi S., Soria C., Bureau J., Lorans G., Soria J., Faure J.P., Pouliquen Y. Secretion of plasminogen activators and plasminogen activator inhibitors by normal and dystrophic corneal fibroblasts: regulation by growth factors.

XIII Congress International Society on Thrombosis and Haemostasis, Amsterdam,1991.

[88] Mirshahi M., Razaghi A., Mirshahi S., Faure J.P. Arrestin (S-antigen)-like protein in platelets.

XIII Congress International Society on Thrombosis and Haemostasis, Amsterdam,1991.

[89] Mirshahi M., Razaghi A., Oliver J., Faure J.P. Arrestin-like protein in brain.

3th IBRO World Congress in Neuroscience, Montréal, 1991.

[90] de Kozak Y., Mirshahi M., Stiemer R., de Smet M., Frank R., Faure J.P. Modulation of S-antigen induced EAU by neonatal injection of peptides from S-antigen or TNF a or by anti-idiotypic antibody.

10th International Congress of Eye Research, Stresa, 1992.

[91] Mirshahi A., Nato A., Laverne D., Faure J.P., Mirshahi M. Identification of soluble and chloroplastic membrane bound forms of arrestin-like immunoreactive proteins in tobacco and Chlamydomonas cells.

Vth International Conference on Retinal Proteins, Dourdan,1992.

[92] Mirshahi M., Mirshahi S., Nelles L.,Pouliquen Y., Soria C., Soria J. Detection of m-RNA of plasminogen activators and their inhibitors in corneal fibroblasts.

XIth International Congress on Fibrinolysis, Copenhagen, 1992.

[93] Mirshahi S., Vasse M., Soria C., Mirshahi M., Soria J. Adriamycin induced secretion of both IL6 and urokinase by monocytes.

XIth International Fibrinogen Workhop, Oslo,1992.

[94] Vasse M., Mirshahi S., Mirshahi M., Soria C., Borg J.Y., Monconduit M., Soria J. Synergistic effect of lymphocytes in the stimulation induced by monocytes of fibrinogen biosynthesis by hepatocyte cell line.

XIth International Fibrinogen Workhop, Oslo, 1992.

[95] Razaghi A., Borgese F., Nato A., Oliver J., Mirshahi M., Faure J.P. Proteins related to retinal S-antigen (arrestin) in non photosensitive cells.

Vth International Conference on Retinal Proteins, Dourdan, 1992.

[96] Mirshahi M., Mirshahi S., Lopez R., Ghedira I., Soria J., Soria C., Burtin P., Pouliquen Y. Binding of plasminogen to fibroblasts and its extracellular matrix.

XIVth Congress of the International Society on Thrombosis and Haemostasis, New York, 1993.

[97] Mirshahi, A., Cavalcantealves J.M., Nato A., Lavergne D., Mirshahi M., Faure J.P . and Ducreux G. Immunodetection of Arrestin ike proteins in Nicotiana tabacum L. And Ipomoea batatas (L) lam embryogenic cells.

Plant physiology, Montpellier (France) Oct 1993 .

[98] Mirshahi M., Ghedira I., Nicola C., Jenhani F., Faure J.P. Arrestin in ocular tissues.

Joint European research Meeting in Ophtalmology and Vision. (JERMOV) , Montpolier France 1994

[99] Mirshahi M., Thillaye B., Tarraf M., de Kozak Y., Faure J.P. Light-induced changes in S- antigen (arrestin) localizationin retinal photoreceptors: difference between rods and cones and deffective process in RCS rat retinal dystrophy.

The Association for Research in Vision and Ophtalmology (ARVO) Sarassota, USA, 1994

[100] Lebrazi J., Helft G., Vacheron M., Samama M.M., Mirshahi M. et Lecompte T. Humain anti streptokinase antibodies induce platelet aggregation in a Fc/ CD32-dependent manner. Fibrinolysis 8,sup 1; 40 Leuven 1994

[101] Lopez-Alemany R., Mirshahi F., Burtin P., Soria C., Soria J., Faure J.P., Mirshahi M. Generation and characterization of monoclonal antibodies against plasmin receptor from human carcinoma cells.

Fibrinolysis 8,sup 1; 54 Leuven 1994

[102] Lebrazi J., Mirshahi M., Gouin., Samama M.M., et Lecompte T.Streptokinase and ASPAC inhibit the platelet aggregation in vitro by fibrinogenolysis : effect of fibrinogen degradation products X and E generated in plasma .

Fibrinolysis 8,sup 1; 137 Leuven 1994

[103] Agarwal M.K., Mirshahi F., Mirshahi M., Braq S., Chentoufi J., Julienne A., Marie P.J. Evidence for receptor mediated mineralocorticoides hormone action in rat calvaria osteoblasts.

9 th International congress of Endocrinology, Washington, juin,1994.

[104] Mirshahi A.,. Cavalcante Alves J.M, Tichtinsky G., Henry Y., Lavergne D., Ducreux G., Faure J.P., Mirshahi M., Nato A. Plant signal transduction pathways: Arrestin-like proteins are involved in wheat somatic embryogenesis process.

Deuxième Colloque Géneral sur les Sciences Végétales, Saint-Malo Octobre 1994

[105] Mirshahi A., Cadre J.P., Cheniclet C., Nato A., Dubertret G., Pineau B., Faure J.P., Mirshahi M. Immunodetection of protein(s) crossreactive with retinal arrestin in photosensitive membranes of plant chloroplasts .

Joint Europ. Res. Meetings Ophthalmol. Vision (JERMOV) Montpelier Octobr, 1994.

[106] Lopez-Alemany R., Mirshahi S., Faure J.P., Pouliqen Y. Mirshahi M. Binding of plasminogen to corneal fibroblasts and their extracellular matrix. Evidence for a receptor in cell membrane.

Joint Europ. Res. Meetings Ophthalmol. Vision (JERMOV) Montpelier Octobr, 1994.

[107] Nato A, Mirshahi A., Cavalacante Alves J.M., Lavergne D., Ducreux G., Mirshahi M., Faure J.P., DeBuyser J., Tichtinsky G., Kreis M., Henry Y. Are arrestin -like proteins involved in plant signal transduction

8th Int. Congress of Plant Tissue and cell culture, Frienze, novembre 1994.

[108] Abdelouahed M., Elalamy S., Lebrazi J., Gerard H., Mirshahi M., Leucrubier C., Samama M., Lecompte T. Streptokinase modifies in vitro platelet aggregation by two mechanisms: defect by fibrinogenolysis and activation by immunological reaction.

XIV th congress of international society on thrombosis and haemostasis Jerusalem, 1995

[109] Mirshahi M., Nicolas C., de Kozak Y., Faure J.P., Agarwal M.K. Mineralocorticoid hormon receptor and action in the eye.

The Endocrine Society, Washington, USA, 1995

[110] Mirshahi M., Agarwal M.K. The mineralocorticoid receptor expression is not altered in hypertensive rats.

The Endocrine Society, Washington,USA, 1995

[111] Agarwal M.K., Mirshahi M.The mineralocorticoid receptor expression is not altered in hypertensive rats.

6 th Asian -Pasific congress of nephrology Hong kong 1995

[112] Agarwal M.K., Mirshahi M. The mineralocorticoid receptor expression is not altered in hypertensive rat.

Thailand seminars in Nephrology, Bankok, Thailand1995

[113] Mirshahi M., Nicolas C., de Kozak Y., Faure J.P., Agarwal M.K.Mineralocorticoid hormones, influence the growth of ocular cells in vitro.

10 th International congress of endocrinology, Sanfrancisco. 1996.

[114] Mirshahi M., Nicolas C., d'Hermies., Faure J.P., Agarwal M.K. Immunocytochemical analysis of mineralocorticoid receptor in the human eye.

10 th nternational congress of endocrinology, Sanfrancisco USA.1996.

[115] Mirshahi S., Lopez-Alemany R., Soria J., Soria C., Faure J.P., Burtin P., Poulquen Y.,Mirshahi. M. Immunolocalization of enolase related plasminogen receptor (55-60 kDa) in cornea.

XIII international congress on fibrinolysis and thrombolysis Barcelona Spain.1996.

[116] Lebrazi J., Lopez-Aleany R., Soria J., Burtin P.Faure J.P., Samama M., Mirshahi M. Implication of plasminogen binding for platelet agregation induced by streptokinse-anti streptokinase complexes.

XIII international congress on fibrinolysis and thrombolysis Barcelona Spain, 1996.

[117] Nicola-Lévêque C., Gheidaria I., Mirshahi A., Jenhani F., Faure J.P., Mirshahi M. b-arrestin related proteins in retina.

FEBS 96, Barcelona , Spain.1996.

[118] Mirshahi S., Lopez-Alemany R., Soria J., d'Hermies F., Mirshahi F., Soria C., Burtin P., Faure J.P., and Mirshahi M. immunolocalization of 55-50 kDa plasminogen receptor in ocular tumor cells by monoclonal antibodies.

American Association for Clinical Chemistry and Canadian Society of clinical Chemistry 96; Chicago USA.1996.

[119] Mirshahi M. et Agarwal M.K., Analysis of the mineralocorticoid receptor during rodent hypertension.

American Association for Clinical Chemistry and Canadian Society of clinical Chemistry 96; Chicago USA.1996.

[120] Mirshahi T., Irache J.M., Mirshahi M., Orrechioni A.M. Propriétés immunologiques des nanoparticules de legumine (protéine végetale issues de pisum sativum).

Journée de recherche Univ. Paris XI, 1996.

[121] Razaghi A., Barque J.Ph., Chacun H., Mirshahi M., Faure J.P., Bonaly J. Cractérisation d'une protéine apparentée à l'Antigène S/arrestine chez Euglena gracilis.

Journée de recherche Univ. Paris XI,1996.

[122] Golestaneh N., Menasche M., Mirshahi S., Lehmann C., Robert L., Faure J.P., Pouliquen Y., Mirshahi M. Immunolocalization of a 67 kDa elastin/laminin binding protein in cornea.

Joint European research Meeting in Ophtalmology and Vision (JERMOV), Montpellier, France. 1996.

[123] Mirshahi S., Lehmann C., Soria J., Soria C., Faure J.P., Poliquen Y. Mirshahi M. Urokinase and urokinase receptor in corneal fibroblasts.

Joint European research Meeting in Ophtalmology and Vision (JERMOV), Montpellier. France, 1996.

[124] Agarwal M.K., Mirshahi M. The mineralocorticoid receptor expression is not altered in hypertensive rat.

VI Conference International Clin. Pharmacol. Therap. B. A. Argentine.1996.

[125] Agarwal M.K., Mirshahi M. Mirshahi A., Nicolas C., Faure J.P. The Mineralocorticoid Receptor in Ocular Tissues .

Mol. Biol. of the Cell , Sanfracisco, USA.1996.

[126] Nicolas C., Ghedira I., Hecquet C., Faure J.P., Mirshahi M.Bovine retinal pigment epithelial cells express arrestin (S-antigen) and -arrestin proteins.

Vision Research Fort Lauderdale, Florida USA.1977.

[127] Mirshahi M., C. Nicolas, J. P. Faure, M. K. Agarwal Ocular tissues possess the mineralocorticoid receptor.

The Association for Research in Vision and Ophtalmology (ARVO) Fort Lauderdale, Florida USA. 1997.

[128] Nicolas C., Ghedira I., Faure J.P., Mirshahi M. b-Arrestin -related proteins in ocular tissues.

The Association for Research in Vision and Ophtalmology (ARVO) Fort Lauderdale, Florida USA. 1977.

(129] Mirshahi S., R. Lopez-Alemany , J. Soria , C. Soria J.P. Faure , P. Burtin ,Y. Pouliquen, M. Mirshahi Enolase related plasminogen receptor in cornea.

The Association for Research in Vision and Ophtalmology (ARVO) Fort Lauderdale, Florida USA. 1997.

[130] Mirshahi M., Nicolas C., Hecquet C., Faure J.P., Agarwal M.K. Récepteur de minéralocorticoïde dans les tissus oculaires.

3e Colloquede la Société des Neurosciences Bordeaux France. 1997

[131] Mirshahi M., Mirshahi S., Nicolas C., Lounes K. C., Hecquet C., Agarwal M. K. Mineralocorticoids in human ocular tissues.

FEBS Amesterdam, The Netherland.1997.

[132] Nicolas C., Razaghi A., Mirshahi S., Faure J.P., Mirshahi M. Arrestin related proteins in platelets.

XVI th Congress of the InternationalSociety on Thrombosis and Haemostasis Florence Italy.1997.

[133] Mirshahi S., Lopez-Alemany R., Mirshahi F., Soria J., d'Hermies F., Soria C., Burtin P., Faure J.P., Mirshahi M. Immunolocalization of enolase related plasminogen receptor (55-60 kDa) in ocular tumor cells by monoclonal antibodies.

XVI th Congress of the InternationalSociety on Thrombosis and Haemostasis Florence Italy.1997.

[134] Mirshahi M., Mirshahi S., Nicolas C., Hecquet C. Agarwal M. K.. Immunochemical analysis of the sodium channel and the mineralocorticoid receptor in fibroblasts isolated from human cornea.

The Endocrine Society 79 th Meeting Minneapolis USA, 1997.

[135] Mirshahi M., Nicolas C., Mirshahi S., d'Hermies F., Faure J. P., Agarwal M. K. Immunochemical demonstration of the mineralocorticoid and the sodium channel in human ocular tissues.

The Endocrine Society 79 th Meeting Minneapolis USA, 1997.

[136] Mirshahi M., Mirshahi S., Nicolas C., Michal Z., Dagonnet F., Hecquet C., Lounes K.C., d'Hermies F., Pouliquen Y., M. K. Agarwal. Steroid hormone action on the amiloride-sensitive sodium channel.

XIII International Congress of Comparative Endocrinolgy. Yokohama Japan.1997.

[137] Mirshahi M., Mirshahi S., Nicolas C., Mishal Z., Dagonnet F., Hecquet C., Ferrari P., Pouliquen Y., Agarwal M. K. Mineralocorticoid hormone action in Corneal primary cultures and leukemic cell line.

The American society for cell biology, Annual Meting. Washington DC. USA.1997.

[138] Mirshahi M. Etude d'action des hormones corticoides dans l'oeil .

Vision et Recherche Retina France, 1997.

[139] Mirshahi M., Ayani E., Golestaneh N., Nicolas C., Ferrari P., Agarwal M. K. Mineralocorticoid antagonist are teratogenic to rat embryos in vitro.

The American society for cell biology, Washington DC. USA, 1997.

[140] MirshahiM., Mirshahi S., Golestaneh N.., Michal Z., Hecquet C. Agarwal M. K. Receptor mediated effects of Mineralocorticoid in human leukemic cell lines.

80 th annual meeting of the Endocrine Society, New Orleans, USA, 1998

[141] Mirshahi M., Mirshahi S., Golestaneh N., Michal Z., Hecquet C. Agarwal M. K. Mineralocorticoid receptor and action in human leukemic cell lines.

VIIIth Adrenal Cortex Conferrence. Manoir des Sables Orford Québec Canada 1998.

[142] Mirshahi M., Ayani E., Golestaneh N., Nicolas C., Ferrari P., Agarwal M. K. Antimineralocorticoids are teratogenic to rat embryos in vitro.

80 th annual meeting of the Endocrine Society, New Orleans, USA, 1998.

[143] MirshahiM., Mirshahi S., Nicolas C., Hecquet C., Michal Z., Dagonnet F., Agarwal M. K. Mineralocorticoid receptor and action in Ocular cells and tissues.

Xth International congress on Hormonal Steroids.Québec city Canada, 1998.

[144] Golestaneh N., Nicolas léveque C., Ferrari P., Agarwal M.K., Mirshahi M. The Amilroid Sodium Sensitive Channel in Rodent Retina.

European association for Vision and Eye research (EVER), Palma de Mallorca, Spaine, octobr, 1998

[145] Golestaneh N., Nicolas C., Ferrari P., Agarwal M.K., Mirshahi M. Ontogenical study of mineralocorticoid receptor in the rat retina .

European association for Vision and Eye research (EVER), Palma de Mallorca, Spaine, october, 1998

[146] Mirshahi S., Soria C., Mirshahi M., Golestaneh N., Lounes K., N'Guyen G., Grateau G., Chevet D., mousson C.T., Rifle G., Soria J. Fibrinogen biosyntesis by renal mesangial cell. a possible role in renal amyloid deposis.

International fibrinogen Workshop, Cleveland, USA, 1998.

[147] Merodio M., Arnedo A., Mirshahi T., Renedo M.J., Mirshahi M., Irachi J.M. Preparation and evaluation of ganciclovir loaded albumine nanoparticles.

13th Anual meeting of the C.T.R.V. Paris, France, 1998.

[148] Merodio M., Arnedo A., Mirshahi T., Mirshahi M., Irachi J.M Desarrollo de nanoparticulas de ganciclovir para el tratmiento de infecciones citomegalovirus.

1er Jornadas de tecnologia farmaceutica, Universidad de San Pablo -CEU/AEFI, Spain, 1999.

[149] Merodio M., Campanero M.A., Mirshahi M., Mirshahi T., Irachi J.M. Development of a new and sensitive method for the determination of ganciclovir by reversed -phase hirh performance liquid chromatography.

HPLC, 99, International congress, Gronada, Spain, 1999.

[150] Merodio M., Arnedo A., Mirshahi T., Renedo M.J., Mirshahi M., Irachi J.M; Preparation and evaluation of ganciclovir loaded albumin nanaoparticles.

13 th Anual Meeting of the G.T.R.V. Paris, france,December 1999.

[151] Golestaneh N., Nicolas C., Picaud S., Ferarri P., Mirshahi M. The ontogeny of Epithelial Sodium Channel in rodent retina.

The Association for Research in Vision and Ophtalmology (ARVO) Fort Lauderdale, Florida USA, 1999.

[152] Lehmann C., Mirshahi S., Mirshahi M. , Y. PouliquenY. Urokinase (uPA) und Urokinaserezeptor (uPAR) in Hornhautfibroblasten

Jahrestagung der DOG, Germany, 1999

[153] Lehmann C., MirshahiS., Soria J., Pouliquen Y., Mirshahi M., Rieck P. Urokinase (UPA) and urokinase receptor (UPAR) in corneal fibroblasts.

97th DOG Annual Meeting, Germany, 1999

[154] Merodio M., Arnedo A., Golestaneh N., Mirshahi T., Mirshahi M., Irachi J.M

Activity of ganciclovir- loaded bovine serum albumin nanoparticles. Berlin, 2000.

[155] Mirshahi M., Golestaneh N. Ontogeny and molecular identity of the mineralocorticoid receptor in the rat retina.

The Association for Research in Vision and Ophtalmology (ARVO) Fort Lauderdale, Florida USA, 2000.

[156] Golestaneh N., deKozak Y., Kleine C., Mirshahi M. The mineralocorticoid hormone receptor in the rat Müller glial cells.

The Association for Research in Vision and Ophtalmology (ARVO) Fort Lauderdale, Florida ,USA, 2000.

[157] M. MirshahiM., Emadi S.,Valamanesh F., Golestaneh N., Le Bousse-Kerdiles MC., Agarwal MK, Mineralocorticoids influence the growth and diferentiation of pluripotent human stems cells. The Endocrine society's 83rd annual meeting, june, Denver, USA. 2001.

[158] Golestaneh N., Klein C.,Valamanesh F., AgarwalMK., Mirshahi M. Mineralocorticoid hormone regulates the amilorid sesitive sodium channel in vascular endothelial cells .

Coeur, Vaisseaux, Artériosclérose. Montpellier, France, 2001.

[159] Golestaneh N., Chen W., Valamanesh F., Nicolas C., AgarwalM.K., Mirshahi M. Mineralocorticoid receptor signaling regulates the epithelial sodium channel in vascular endothelial cells and requiers an intact cytoskeleton. The Endocrine society's 83rd annual meeting, June, Denver, USA, 2001.

[160] Valamanesh F., Chen W., Mirshahi T., Soria J., Agarwal MMK., Mirshahi M.Visualization of aldosterone mediated -volume increase in endothelial cells migration through a fibrine matrix model. The Endocrine society's 83rd annual meeting, June, Denver, USA, 2001

[161] Sakly N., Mirshahi P., Soria J., Mankai A., Ghedira I., Mirshahi M. Serum angiogenic activity of type I diabetes patients assessed by tube formation test on matrigel.

The 4th international congress on autoimmunity, Budapest, Hungary, Novembre 3-7, 2004.

[162] Sakly N., Mirshahi P., Soria J., Ghedira I., Mirshahi M. Increased angiogenic activity in SLE patients with lupus nephritis.

The 4th international congress on autoimmunity, Budapest, Hungary, Novembre 3-7, 2004.

[163] Sakly N., Mirshahi P., Soria J., Landolsi H., Ghedira I., Mirshahi M..

Anti-endothelial cell antibodies in Tunisian systemic lupus erythematosus patients and their relation with clinical syndromes.

The 4th international congress on autoimmunity, Budapest, Hungary, Novembre 3-7, 2004.

[164] Sakly N., Mirshahi P., Soria J., Mirshahi M., Ghedira I. , Mirshahi M.. Anti-endothelial cell antibodies determination by Cyto-ELISA: a comparative study between three cell types used as substrates.

The 4th international congress on autoimmunity, Budapest, Hungary, Novembre 3-7, 2004.

[165] Sakly N., Mirshahi P., Soria J., Ghedira I., Mirshahi M. Anti-double stranded DNA auto-antibodies correlate with increased serum angiogenic activity in patients with systemic lupus erythematosous.

The 6th European Lupus Meeting. The Royal College of Physicians, London, 2005.

[166] Sakly N., Mirshahi P., Soria J., Ghedira I., Mirshahi M. Effect of IgG anti-endothelial cell antibodies against HBMEC on the investigation of angiogenesis by the in vitro HBMEC tube formation test in patients with SLE.

The 6th European Lupus Meeting. 03-05 Mars 2005. The Royal College of Physicians, London, 2005.

[167] ] Sakly N., Mirshahi P., Soria J., Ghedira I., Mirshahi M. Etude comparative de la recherche des anticorps anti-cellules endothéliales par Cyto-ELISA en utilisant trios substrats cellulaires différents.

IIIèmes journées scientifiques de la Société Tunisienne d’Immunologie, Sfax, 3-4 Décembre 2004.

[168] ] Sakly N., Mirshahi P., Soria J., Ghedira I., Mirshahi M. Angiogenèse augmentée chez les patients lupiques ayant une atteinte rénale.

IIIèmes journées scientifiques de la Société Tunisienne d’Immunologie, Sfax, 3-4 Décembre 2004.

[169] Rafii A., Mirshahi P., Simon A., Faussat AM., Marie JP., Pujade lauraine E., Soria J., Mirshahi M. Stromal cells extracted from ovarian cancer express functional multi drugs resistance proteins: ATP bindig casset and Major vault protein.

ASCO Atlanta, 2006.

[170] Ducros E., Rafii A., Faussat AM., Berthaut A., Mirshahi P., Soria J., Mirshahi M.

Acquisition of an SDF-1-induced invasive phenotype by breast adenocarcinomas cells MDA-MB231; involvement of Rho GTPases. EACR, Budapest, 2006.

[171] Rafii A., Mirshahi P., Simon A., Faussat AM., Ducros E., Marie JP., Pujade-Lauraine E., Soria J, Mirshahi M. Stromal cells extracted from ovarian cancer express functional multi drugs resistance proteins: ATP bindig casset and Major vault protein.American Society of Clinical Oncology (Orlando, USA), Mai 2006.

[172] Berthaut A, Mirshahi P, Soria J., Mirshahi M, Legeais JM. VEGFs and their receptors on corneal fibroblasts, role of FLT1

ARVO Florida, USA, 2006

[173] Ducros E, BerthautA, Mirshahi P., Lemarchand S., Soria J., Legeais JM., Mirshahi M.,

Expression of extracellar matrix proteins Fibulin-1 and Fibulin-2 by human corneal fibroblasts.

ARVO Florida,USA, 2006

[174] Ducros E., Rafii A., Faussat AM, Berthaut A., Mirshahi P., Soria J, Mirshahi M. Acquisition of an SDF-1-induced invasive phenotype by breast adenocarcinomas cells MDA-MB231; involvement of Rho GTPases.

EACR Budapest, Hungary, 2006.

[175] Rafii A., Mirshahi P., Simon A., Faussat AM., Ducros E., Marie JP., Pujade-Lauraine E., Soria J, Mirshahi M. Role of new stromal cells extracted from ovarian cancer in tumor protection.

EACR , Budapest, Hungary, 2006.

[176] Ducros E., Rafii A., Faussat AM, Berthaut A., Mirshahi P., Soria J, Mirshahi M. Influence du SDF-1 sur l'implantation médullaire des adénocarcinomes mammaires; études in vitro du comportement de la lignée cellulaire MDA-MB231 Journée des Cordeliers, Paris, 2005..

[177] Mirshahi P., Berthaut A., Ducros E., Valamanesh F., Soria J., Mirshahi M.

Expression of pro-inflammatory and angiogenic factors by retinal pigment epithelial (RPE) cell lines, in vitro. ARVO (Fort Lauderdale, Florida), 2007

[178] Ducros E., Berthaut A., Mirshahi P., Valamanesh F., Lemarchand S., Agarwal MK., Soria J. , Mirshahi M. Expression of aldosterone synthase "CYP11B2" by retinal vascular endothelial cells. ARVO (Fort Lauderdale, Florida) USA, 2007.

[179] Rafii A., Mirshahi P., Faussat A.M., Ducros E., Couderc B., Poupot M., Marie J-P, Querleu D., Favre G., Soria J., Mirshahi. M.

New stromal cells extracted from ovarian cancer ascitis specifically interact with tumor cells and induce chemoresistance through trogocytosis and expression of functional multi drugs resistance proteins.

AACR , Los Angeles, USA, 2007

[180] Berthaut A., Ducros E., Mirshahi P., Lemarchand S., Agarwal MK., Legeais JM., Mirshahi M. Retinal vascular endothelial cells express aldosterone synthase.

ENDO 07, Toronto, Canada, 2007

[181] Mirshahi P., Berthaut A., Ducros E., Soria J., Agarwal MK., Mirshahi M. Pleiotropic gene modulation by aldosterone in the human bone marrow endothelial cells. ENDO 07, Toronto, Canada, 2007 .

[182] Berthaut A., Mirshahi P., Ducros E., Soria J., Mirshahi M. Expression of IL-3 (hematopoietic factor) by human retinal pigment epithelial (RPE-19) immortalized cell line. ENDO 07, Toronto, Canada, 2007.

[183] Ducros E., Mirshahi S.S. , Soria J., Agarwal M. K., Mirshahi M. Up- regulation of activated protein-C receptor on human endothelial cells by Aldosterone .

ISTH,Genève 2007

[184] Ducros E., Darvishi S., Mirshahi S.S., Rafii A., Soria J., Mirshahi M. Human Malignant Cells Express Functionally Active Endothelial Protein C Receptor.

ISTH, Genève 2007

[185] Ducros E., Darvishi S., Mirshahi SS., Faussat AM., Rafii Tabrizi A., Soria J, Mirshahi M. Functional endothelial protein C receptor detected on human malignant cells.

International Conference on Thrombosis and Hemostasis Issues in Cancer (Bergame, Italie), Octobre 2007.

[186] Ducros E., Mirshahi SS., Perrot JY., Faussat AM., Chauvenet L., Daggonet F., Pujade-Lauraine E., Soria J, Mirshahi M. Dual implication of Endothelial Protein C receptor (EPCR) in cancer homoeostasis.

International Conference on Thrombosis and Hemostasis Issues in Cancer (Bergame, Italie), Octobre 2007.

[187 ] Ducros E., Mirshahi S., Leviel F., Berthaud A., Soria J., Mirshahi M. Basal Expression of Endothelial Cell Protein C Receptor is regulated by Endogeneous Aldosterone via Aldosterone Synthase.

ISTH, Genève 2007

[ 188 ] Sakly N., Mirshahi P., Soria J., Ghedira I., DucrosbE., Mirshahi M.

Plasma angiogenic activity in patients with systemic lupus erythematous .

ISTH, Genève 2007

[189 ] Berthaut A.V., Mirshahi P., Soria J., Sabatier P., Le Marchand S., Mirshahi M., Legeais J.M. Generation of human corneal fibroblasts-like phenotype from mesenchymal stem cells differentiation in vitro

Journée de la recherche clinique et fondamentale, Paris 2007

[190] Berthaut A.V., Mirshahi P.,Soria J.,Mirshahi M.,Legeais J.M. IGF via ERK pathway signalling induces human corneal fibroblasts network formation in vitro. La société Française d’Ophtalmologie Paris,2008

[191] Varin R., Mirshahi S., Mirshahi P., Li H., Kierzek G., Vigneau JF., Perzborn E., Mirshahi M. , Soria C., Soria J. The effects of rivaroxaban, an oral, direct Factor Xa inhibitor on clot structure and degradability.

14th World Congress on Heart Disease, Toronto, Canada, 2008.

[192] Varin R., Mirshahi S., Mirshahi P., Li H., Kierzek G., Vigneau JF., Marie JP., Perzborn E.,

Mirshahi M., Soria C., Soria J. Enhanced thrombolysis with rivaroxaban, an oral, direct Factor Xa inhibitor; therapeutic potential in patients with thrombosis.

51 st Annual meeting of American Society of Hematology. San Francisco 2008

[193] Mirshahi P., Berthaut A., Ducros E., Soria J., Mirshahi M. Pleiotropic gene modulation by aldosterone in the human endothelial cell, 14th World Congress on Heart Disease, Toronto, Canada, 2008.

[194] Benabbou N., Mirshahi M. Influence d’IGF1 secrété par le microenvironnement tumoral sur la survie des cellules cancéreuses. Journée des jeunes chercheurs, (Paris, France), Avril 2008.

[ 195 ] Ducros E., Berthaut A., Mirshahi P., Lemarchand S., Soria J., Legeais JM., Mirshahi M. Implication de la Fibuline 1 dans les phénomènes de cicatrisation. Conférence nationale des Plaies et Cicatrisations (Paris, France), Janvier 2008.

[ 196] Ducros E., Darvishi S., Mirshahi SS., Soria J., Rafii A., Mirshahi M. Détection de l’EPCR dans des cellules tumorales.

Journée des Jeunes Chercheurs des Cordeliers (Paris, France), Avril 2008.

[197] Karroum A., Mirshahi P., Benabbou N., Faussat A.M., Mirshahi M. Hatmi M. Rôle de la MMP-9 et du VEGF dans la vasculomimétisme des cellules MCF-7 résistantes: implication des voies de la PKC et des ERK ½.

Journée de recherche CRC, Paris, France, 2009.

[198] Ducros E., Mirshahi S.S., Berthaut A., Soria J., Mirshahi M. L’aldostérone perturbe l’hémostase en augmentant l’expression par les cellules endothéliales humaines du récepteur de la protéine C.

Groupe de Réflexion sur la Recherche en Cardiologie (Nancy, France), Avril 2009.

[199] Varin R., Mirshahi S., Mirshahi P., Li H., Kierzek G., Vigneau JF., Perzborn E., Mirshahi M., Soria C., Soria J.The therapeutic potential of enhanced thrombolysis with rivaroxaban, an oral, direct factor Xa inhibitor, in patients with thrombosis. 49th Annual Scientific Meeting meeting of the British Society of Haeamtology. Brighton, UK, 2009.

[200] Mirshahi P., A. Rafii, L. Vincent, A. Berthaut, R. Varin, G. Kalantar, C. Marzac, O. calandini3, JP. Marie, C. soria, J. Soria, M. Mirshahi. Vasculogenic mimicry of acute leukemic bone marrow stromal cells, Role of IGF-1. International Society on Thrombosis and Haemostasis, XXII congress, Boston , USA, 2009.

[201] Ducros E., Mirshahi S., Bermot C., Mirshahi M., A novel method to analyze endothelial cell protein C receptor. International Society on Thrombosis and Haemostasis, XXII congress, Boston , USA, 2009.

[201] Mirshahi S. , Soria C. , Chidiac J., Varin R., Pujade-Lauraine E., Woodhams B., Mirshahi M., Soria J. Plasma Soluble fibrin level, a clinically useful predictor of thrombosis in cancer patients. International Society on Thrombosis and Haemostasis, XXII congress, 2009, Boston, USA

[202] Benabbou N., Tang R.P, Azzazene D., Bordu C., Agra A. et Mirshahi M. La régulation du P-gp par Insulin-like Growth Factor1 (IGF1) dans les hémopathies malignes). Journée des jeunes chercheurs (Paris, France), Avril 2009

[203] Azzazen D., Benabbou N., Ducros E., Mirshahi M. Expression et régulation de Human Leukocyte Antigen G (HLA-G) dans les hospicells. Journée des jeunes chercheurs (Paris, France), Avril 2009..

[204] Varin R., Mirshahi S., Mirshahi P., Chidiac J., Kierzek G., Marie JP., Mirshahi M., Soria C., Soria J.

Effect of Rivaroxaban, An Oral Direct Factor Xa Inhibitor, On Whole Blood Clot Permeation and Thrombolysis: Critical Role of Red Blood Cells

51 st Annual meeting of American Society of Hematology , New Orleans 2009

[205] Lis R., Mirshahi P., Poupot M., Mery M., Fournié J.J., Querleu D., Mirshahi M., Rafii A. Ovarian cancer cells aquire chemoresistance throuth intercellular transfer of MSC derived PgP.

International conference on tumor microenvironement, Versailles, France, 2009.

[206] Berthaut A., Mirshahi P., Benabbou N., Ducros E., Agra A.,Therwath A. , Legeais J. M. and Mirshahi M. Insulin growth factor promotes human corneal fibroblast network formation in vitro.

International society for eye research (Montreal, Canada), Juillet 2010.

[207] Fayol N., Berthaut A., Mirshahi P., Benabbou N., Ducros E., Agra A.,Therwath A., Legeais J. M. and Mirshahi M. Insulin growth factor promotes human corneal fibroblast network formation in vitro.

Société Française d’ophtalmologie (Paris, France), 2010.

[208] Rocher N., Berthaut A., Bourges J., Mirshahi P., Benabbou N.,Azzazene D., Bordu C., therwath A.,Legeais J.M., Mirshahi M. Vascular endothelial growth factor receptor-1 (VEGFR-1) expression in human corneal fibroblast decreased with age.

ARVO (Fort Lauderdale, USA), 2010.

[209] Benabbou N., Mirshahi P., Berthaut A., A. Legeais J.M. Mirshahi M. Chemokines rantes, CCL11, CCL24, CCL26 and CCL28 expression by retinal pigment epithelium cells and their up regulation by aldosterone.

Endo-2010, Sanfrancisco, USA.

[210] Rocher N., Berthaut A., Bourges J., Mirshahi P., Benabbou N., Azzazene D., Bordu C., therwath A., Renard G., Legeais J.M., Mirshahi M. Vascular endothelial growth factor receptor-1 (VEGFR-1) expression in human corneal fibroblast decreased with age.

Société Française d’ophtalmologie, Paris, France, 2010.

[211] Mirshahi M.La Langue et de la civilisation Iranienne en Asie Centrale, INALCO, 2010.

[212] Mirshahi M. Stem cell therapy in cardiac desease, Faculté de Médecine d’Avicenne, Tadjikistan, Mars 2010.

[213] Mirshahi M., Bon marrow CD-133 cells in liver stem cell therapy, Institut de Gastroentrologie, Académie des Sciences, Tadjikistan, Juillet 2010.

[214] Mirshahi M., Expression du VEGF dans le stroma cornéen: peut-on rajeunir la cornée. Cornéec 2010, Diplôme d’université de Microchirurgie Ophtalmologique, 2010.

[215] Lis R., Touboul C., Mirshahi P., Ali F., Mathew S., Nolan D.J., Maleki M., Abdolla S.A., Raynaud C.M., Querleu D., Al-Zawani E., Malek J., Mirshahi M., Rafii A. Tumor associated mesenchimal stem cells protect ovarian cancer cell from hyperthermia through CXCL12. AACR Meeting, Washington, USA, 2010.

[216] Benabbou N., Mirshahi P., Berthaut A., Legeais J.M., Mirshahi M. Chemokines rantes, CCL11, CCL24, CCL26 and CCL28 expression by retinal pigment epithelium cells and their up regulation by aldosterone.International society for eye research (Montreal, Canada), Juillet, 2010.

[217] Mirshahi M. Les cellules T régulateur et lupus erithemataux systémiques, lupus, Monasir, tunesie, Nov. 2010.

[218] Mirshahi. La Langue et de la civilisation Iranienne en Asie Centrale (Les langues de Pamir), INALCO, 2011

[219] Mirshahi M., Insuline growyh factor, IGF dans la cornée ? Un facteur décisif, Cornée 2011, Diplôme d’université de Microchirurgie Ophtalmologique 2011.

[220] Gulmuradov T.N. , Barotov A., Rizoev E., Karimzade B., Rahmatov M., Kurbonov U., Khidirov M., Muminjonov S., Didari A., Irgasheva J., Gaibov A. , Rahmonov S., Bobokhojaev U., Mirshahi M. Radionuclide Investigations Of Heart In Patients With Coronary Heart Disease And Pos-Tinfarction Cardiosclerosis After Cell Therapy. Mirojov G., Dustov A. , Rahimov Z., Olimov N., Navjuvonov

International academy of cardiology, 16th world congress on heart disease, annual scientific sessions, Vancouver, Canada, 2011.

[221] Barotov A.K., Gulmuraov T.G., Kurbonov U.A., Gaibov A.D., Karimzade B.D., Khidirov M.A., Muminnjanov S.A., Rizoev E.F., Rahimov Z.Y., Olimov N.Kh., Navjuvonov N.M., Mirojov G.K., Dustov A., Rahmatov M.K., Didory A., Irgasheva J.Z.,.Rahmonov S.B, Bobokhojaev O., Mirshahi M. Angiographic Aspects Of Implantation Of Stem Cells In Ischemic Heart Diseases

International academy of cardiology, 16th world congress on heart disease, annual scientific sessions, Vancouver, Canada, 2011.

[222] Varin R., Mirshahi S., Mirshahi P., Klein C., Chidiac J., Perzborn E., Contant G., Mirshahi M., Soria C., Soria J. Whole blood cells enhance clot resistance to lysis: improvement by rivaroxaban a factor xa inhibitor

XXIII Congress of the International Society on Thrombosis and Haemostasis. Kyoto July 2011.

[223] Ducros E., Mirshahi S., Azzazene D., Camilleri-Broët S., Mery E., Al Farsi H., Althawadi H., Besbes S., Chidiac J., Pujade- Lauraine E., Therwath A., Soria J., Mirshahi M. Endothelial protein C receptor expressed by ovarian cancer cells can be a biomarker of cancer expansion.

XXIII Congress of the International Society on Thrombosis and Haemostasis. Kyoto July 2011.

[224] Gaibov A.D., Kurbonov U.A., Karimzade B., Gulmuradov T.G., Barotov A.K., Rizoev E.F., Khidirov M.A., Muminnjanov S.A., Didary A., Irgasheva J., Rahimov Z.Y., Olimov N.Kh., Navjuvonov N.M., Mirojov G.K., Dustov A., Rahmatov M.K., Rahmonov S.B., Bobokhojaev O., Mirshahi M. Our Experience of Treatment of Occlusive Diseases Of Lower Limb Using Autologous Stem Cells.

International academy of cardiology, 16th world congress on heart disease, annual scientific sessions, Vancouver, Canada, 2011.

[225] Kurbonov U., Khidirov M., Muminjonov S., Didary A., Irgasheva J., Rahmatov M., Mirojov G., Dustov A., Gulmuradov T., Barotov A., Rizoev E., Gaibov A., Karimzade B., Rahmonov S., Bobokhojaev O., Rahimov Z., Olimov N., Navjuvonov N., Mirshahi M. The use of autologous stem cells CD133 + for regenerative treatment of cardio-vascular diseases.

International academy of cardiology, 16th world congress on heart disease, annual scientific sessions, Vancouver, Canada, 2011.

[226] Rahmonov S., Bobokhojaev O., Rahimov Z., Olimov N., Navjuvonov N. , Kurbonov U., Mirojov G. , Dustov A., Gulmuradov T., Barotov A., Rizoev E., Gaibov A., Karimzade B., Rahmatov M., Khidirov M., Muminjonov S., Didary A., Irgashev J., Mirshahi M..Treatment myocardial infarction by bone marrow autologous stem cells CD 133+ .

International academy of cardiology, 16th world congress on heart disease, annual scientific sessions, Vancouver, Canada, 2011.

[227] Bhatt S., Pulpytel J., Mirshahi M., Arefi-Khonsari F. Catalyst Free Plasma Assisted Copolymerization of Poly (ε-caprolactone)-Poly (ethylene glycol) copolymer developed by low pressure inductively exited PECVD for tailored cell adhesion.

20th international conference in plasma chemistry, Philadelphia, USA, 2011.

[228] Al Farsi H., Lis R., Al Thawadi H., Azzazen D., Soria J., Therwat A., Pujade Laurain E., Rafii A., Mirshahi M. Ovarian cancer cell line, OVCAR-3 is a suitable model for studying ovarian cancer stem cells Research .

Stem cell research, Qatar,Feb. 2012.

[229] Rahimov Z., Barotov A., Dustov A., Khidirov M., Gulmuradov T., Mirojov G., Karimzade B., Navjuvonov N. Olimov N., Rizoev E., Gaibov A., Rahmatov M., Muminjonov S., Didary A., Irgasheva J., Therwath A., Bobokhojaev O., Kurbonov U., Rahmonov S., Mirshahi M. Dynamics of myocardial perfusion in patients with coronary heart disease and post infarction cardiosclerosis after stem cell therapy

Stem cell research, Qatar, Feb. 2012.

[230] Al Thawadi H., Mirshahi S., Al Farsi H., Azzazen D., Besbes S., Pujade-Lauraine E., Therwath A.,Soria J., Mirshahi M . Influence of Active and Non-active Protein C on Human Ovarian Cancer stem cell

Stem cell research, Qatar, Feb. 2012

[231] Kurbonov U., Khidirov M., Gaibov A., Muminjonov S., Didary A., Irgashev J., Mirshahi M. Dynamics of myocardial perfusion in patients with coronary heart disease and post infarction cardiosclerosis after stem cell therapy.

Stem cell research, Orumchi, China, Avril, 2012.

[232] Pulpytel., Bhatt S., Mirshahi M., Arefi-khonsari F., Cell adhesion and morphology on plasma copolymerized PEG-PCL thin films

4th International conference on plasma medicine, Orléans France, 2012.

[233] Arefi-Khonsari F., Bhatt S., Pulpytel J., Mirshahi M. Catalyst Free Plasma Assisted Copolymerization of Poly (ε-caprolactone)-Poly (ethylene glycol) for Biomedical Applications.

13th International Conference on Plasma Surface Engineering, September 10 - 14, Garmisch-Partenkirchen, Germany, 2012.

[234] Tarraf M, Faure., J. P., Mirshahi M. Auto and allografts of larval eye nodes generate functional photoreceptors and a viable eye in the pleurodeles ,

ISER, Berlin, Germany, 2012

[235] Z. Rahimov, A. Barotov, A. Dustov, M. Khidirov, T. Gulmuradov, G. Mirojov, B. Karimzade, N. Navjuvonov , N. Olimov, E. Rizoev, A. Gaibov, M. Rahmatov, S. Muminjonov, A. Didary, J. Irgashev, A. Therwath,O. Bobokhojaev, U. Kurbonov, S. Rahmonov, M. Mirshahi. Dynamics of myocardial perfusion in patients with coronary heart disease and post infarction cardiosclerosis after stem cell therapy. International academy of cardiology,

16th world congress on heart disease, annual scientific sessions, Toronto, Canada, 2012.

[236] Bhatt S., Pulpytel J., Mirshahi M. Arefi-Khonsari F., Plasma Polymerized Poly (ε-Caprolactone)-Poly (ethylene glycole) Copolymer Coatings - As a Biodegradable Carrier for Controlled Drug Delivery Applications, International Conference on Nanotechnology in Medicine (NanoMED), University College London (UCL), London, UK , 2012.

[237] Bhatt S., Pulpytel J., Mirshahi M. Arefi-Khonsari F., Comparative study of plasma deposited coatings on the biological point of view, GDR ABioPlas, Faculty of Science, Nancy, France , 2012.

[238] Arefi-Khonsari F., Bhatt S., Pulpytel J., Mirshahi M., Catalyst Free Plasma Assisted Copolymerization of Poly (ε-caprolactone)- Poly (ethylene glycol) for Biomedical Applications, HTPP, 24-29, June, Bologna, Italy, 2012

(Oral)

[239] Arefi-Khonsari F., Bhatt S., Mirshahi M., Ben Salem D., Carton O., Pulpytel J., Atmospheric Pressure Plasma Activation and Deposition for Biomaterials, MP1101- Cost Action-Bioplasma, Dublin, Ireland, 2012(Oral)

[240] Dustov A., Bratov A., Kidirov M., Mirajov G., Kurbanov U., Rakhmatov M., Irgasheva J., Gulmuradov T., Rakhmonov S., Mirshahi M.. Exploration of the heart areas by tc-99m mibi scintigraphy after intracoronary infusion of autologous cd133+ cells in patients with myocardial infarction. International Academy of Cardiology 18th World Congress on Heart Disease Annual Scientific Sessions, Vancouver, 2013

[241] Mirshahi M., Le Marchand S. Co-purification of arrestin like proteins with alpha- enolase in bovine myocardial tissues, their implication in clinical heart diseases

International Academy of Cardiology, 18th World Congress on Heart Disease, Annual Scientific Sessions, Vancouver, 2013

[242] Benabbou N., Mirshahi P., Cadillon C., Soria J., Therwath A., Mirshahi M. Hospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2/STAT3 signaling pathway in an ovarian cancer cell line. Peritoneal carcinousis: First workshop on basic science, Paris 2013.

[243] Lis R., Touboul C. Ali E., Mathew S., Nolan DJ., Maleki M., Abdalla SA., Raynaud CM., Al-Azwani E., Malek I., Mirshahi M., Rafii A. Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia throught CXCL12. Peritoneal carcinousis: First workshop on basic science, Paris 2013.

[244] Lis R., Touboul C, Raynaud CM., Al Azwani E., Malek IA., Suhre K., Mirshahi M., Rafii A. mesenchymal cells interaction with ovarian cancer cells triggers pro-metastatic properties. Peritoneal carcinousis: First workshop on basic science, Paris 2013.

[245] Touboul C., Lis R., Al Farsi H., Raynaud .CM., Warfa M., Althawadi H., Mery E., Mirshahi M., Rafii A. Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model. Peritoneal carcinousis: First workshop on basic science, Paris 2013.

[246] Besbes S., Althawadi H., Alfarsi H, Mirshahi S., Tang R., Fava F., Therwath A., Ghedira I., Soria J., Marie JP., Mirshahi M. Association of endothelial protein C receptor (A6936G) haplotype with thrombotic events as a risk factor in acute myeloid leukemia. XXIV congress of the International Society on Thrombosis and Haemostasis, ISTH, Amsterdam, Holland, 2013

[247] Azzazene D., Al Thawadi H., Al Farsi H., Besbes S., Geyl C., Mirshahi S., Pardo J., Faussat A.M., Jeannette S., Therwath A., Pujade-Lauraine E., Mirshahi M. Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of Natural Killer and TH17 helper cells. XXIV congress of the International Society on Thrombosis and Haemostasis, ISTH, Amsterdam, Holland, 2013

[248] Rafii A., Halibi N., Lis R., Touboul C., Mirshahi M. System biology approach to ovarian cancer peritoneal metastasis, Peritoneal carcinosis: First workshop on basic science, Paris, 2013.

[249] Besbes S., Althawadi H., Alfarsi H, Mirshahi S., Tang R., Fava F., Therwath A., Ghedira I., Soria J., Marie JP., Mirshahi M. Endothelial protein C receptor gene SNP-A6936G is an indicator of thrombotic risk in acute myeloid leukemia. Thrombosis and hemostasis issues in Cancer, Bergamo, Italy, 2014.

[250] Althawadi H , Alfarsi H, Mirshahi S , Chidiac J, Besbes S, Therwath A, Pocard M , Soria J, Mirshahi M. Activated protein C up- regulates the ovarian cancer cell migration and promotes unclottability of cancer peritoneal fluid. Congress of the International Society on Thrombosis and Haemostasis XXV, 2015.

[251] Alfarsi H, Althawadi H , Mirshahi S , Ducros E, Therwath A, Pocard M, Soria J , Mirshahi M. Endothelial protein C receptor in breast cancer cells, co-expressed with multidrug resistance protein, inhibits fibrin formation in tumor micro environment. Congress of the International Society on Thrombosis and Haemostasis XXV, 2015.

[252] Mirshahi S, Pocard M , Mirshahi M. Soria J, Measurement of Heparanase Activity in plasma requires the use of sample antithrombin-depletion. XXV Congress of the International Society on Thrombosis and Haemostasis, 2015.

[253] Valinetaj A, Baitukha A, Fakhuri H, Arefi-Khonsari F, Mirshahi M, Sohbatzadeh F, Ovarian cancetr cell treatement using a transporting atmospheric pressure plasma jet, 22em International symposium on plasma chemistry, Antwerp, Belgium, July , 2015

[254] Mrshahi M. Chemoresistance acquisition by ovarian adenocarcinoma cells due to the crosstalks between Mesenchymal stromal cells and macrophages, Cancer Research Institute of Seoul National University Hospital, Septembre 2016.

[255] Mirshahi M, Valamanesh, Batth, Lo Dico, Pulpyte, Pocard. M, Arefi-Khonsari F

Libération contrôlée de la drogue par nano-couches uniformes des copolymères obtenus par plasma radio fréquence de basse pression. Section 28 CNRS, Bordeaux Juin 2016

[256] Shah S, Pimpie C, Al-Dybiat I, Pocard M, Mirshahi M. Peut-on dévier la différenciation des cellules cancéreuses vers les cellules non-prolifératives par l’induction de la différenciation des cellules souches de cancer. Section 28 CNRS, Bordeaux, Juin, 2016.

[257] Besbes S, Helfer H, Najah H, Fourgeaud C, Mirshahi S, Soria J, Pocard M, Ghedira I, Mirshahi M. Production of a functional thrombopoietin by a human ovarian cancer cell line. ISTH, Motpellier, May, 2016.

[258] Fourgeaud C, Derieux S, Mirshahi S, Besbes S, Chidiac J, Mahé I, Contant G, Pocard M, Soria J, Mirshahi M. Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancers. ISTH, Motpellier, May 2016.

[259] Besbes S, Attal R, Mirshahi S, Chidiac J, Mahé I, Pocard M, Soria J, Mirshahi M.

Microparticles derived from ovarian cancer cell line contained genomic and biologically active proteins, including tissue factor involved in coagulation. ISTH, Motpellier, May 2016.

[260] Shah S, Fourgeaud C, Derieux S, Mirshahi S, Contant G, Pimpie C, Lo Dico R, Rveno C, Soria J, Pocard M, Mirshahi M , Absence of thrombotic events in the Gastric signet-ring cell adenocarcinoma patients with high expression of heparanase, Berlin, ISTH 2017 .

[261] Valinataj A., Baitukha A., Shah S., Sohbatzadeh F., Mirshahi M., Arefi-Khonsar F., Deposition of thin PEG films on the inner wall of tube by transporting discharge in atmospheric pressure, International symposium on plasma chemistry, Totronto, Canada, 2017.

[262] Shah S, Al-Dybiat I, Ullah M., Pimpie C Pocard M, Mirshahi M. Peritoneal fluid from ovarian carcinomatosis induces epithelial-mesenchymal cell transition and up regulated neprilysin in mesothelial cells, The 4th Annual Meeting, the international ovarian cancer consortium on tumor microenvironment and drug discovery, Seoul, Korea 23-25 Feb 2017.

[263] Shah S, Al-Dybiat I, Pimpie C,Pocard M, Mirshahi M. Targeting of cancer cells by induction of differentiation of cancer stem cells into non-proliferating cells,” Targeted Anticancer Therapies Congress, Paris, France 6-8March 2017.

[264] Shah S, Al-Dybiat I, Pimpie C, Pocard M, Mirshahi M. Ovarian carcinomatosis microenvironments induce epithelial-mesenchymal-transition and up-regulate protease-procoagulant activity in mesothelial cells, Peritoneal carcinomatosis: 4th workshop on basic science, Paris, France 15 June 2017.

[265] Shah S, Pimpie C, Ullah M, Kaci R, Pocard M, Mirshahi M. Targeting of cancer cells by induction of differentiation of cancer stem cells into non-proliferating cells. Targeted Anticancer Therapies, Paris, France 2017.

[266] ALDybiat I., Baiyukha A, Pillier F., Delbrel S, Pocard M., Khonsari F. A., and Mirshahi M. Biodegradable Nano film generated by Plasma stream, A new window for cancer therapy. Accepted abstract for International conference on Advanced Nano Materials at the university if Surrey. England. September 11-13, 2017.

[267] Baitukha, I. AL-Dybiat, A. Valinataj Omran, M. Mirshahi, J. Pulpytel, F. Arefi-Khonsari. Plasma processing of biologically active membranes at atmospheric and low pressure. Accepted abstract for international symposium on plasma chemistry in Montreal, Quebec, Canada from July 30 to August 4, 2017.

[268] Mirshahi M., Fibrin deposit on the peritoneal surface serve as a niche for cancer expansion., International society of precision cancer medicine. Busan, Korea, 15-19 march 2018

[269] Mirshahi M., Pocard M., How to create the Cytokine-Card for personalized medicine in ovarian carcinomatosis, International society of precision cancer medicine. Busan, Korea, 15-19 march 2018

[270] Mirshahi M., Fibrin deposit on the peritoneal surface serve as a niche for cancer expansion. DIU Carcinoses péritonéales programme, from 3 to 6 April 2018, Paris, Lariboisière Hopsital.

[271] Azazen D, Ullah M, Al-dybiat I, Kaci R, Pocard M., Mirshahi M, Interleukin-1β is an important HLA-G inducing factors in ovarian carcinomatosis,

ISPCM, Annual meeting, Internantional Society of Precision cancer Medecine, Seoul , Korea, 2019

[272] Azadeh Valinataj Omran, Shah Mirshahi, Geneviève Contant, Marc Pocard, Jeannette Soria, Massoud Mirshahi . The role of DNA and Histone in the rigidity and viscoelasticity of fibrin clots. International Socity on Thrombosis and Hemostasis, ISTH 2019, Melbourne, july 6-10, Australia

[273] Iman Aldybiat, Shahid Shah, Shahsoltan MIRSHAHI, Matti Ullah, Jeannette SORIA, Marc POCARD, Massoud MIRSHAHI. Approach in the study of molecular mechanism in cancer cell implantation on the fibrin network. International Socity on Thrombosis and Hemostasis, ISTH 2019, Melbourne, july 6-10, Australia

[274] Matti Ullah, Azadeh valinetaj, Shahsoltan Mirshahi, Jeannette Soria, Warda Aoudjeghout

Geneviève Contant, Marc Pocard, Massoud Mirshahi. Higher Plasma clot elasticity decreases Clot degradability. International Socity on Thrombosis and Hemostasis, ISTH 2019, Melbourne, july 6-10, Australia

[275] Shahsoltan Mirshahi, Matti Ullah, Azadeh Valinetaj, Iman Aldybiat, Geneviève Contant, Marc Pocard, Massoud Mirshahi, Jeannette Soria. Increase in whole blood clot Stiffness in patients with peritoneal carcinomatosis. International Socity on Thrombosis and Hemostasis, ISTH 2019, Melbourne, july 6-10, Australia

[276] Shahid SHAH, Shahsoltan MIRSHAHI, Cynthia PIMPIE, Rea LO DICO, Geneviève CONTANT, Jeannette SORIA, Marc POCARD, Massoud MIRSHAHI. Heparanase: a potential new factor concerned to epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma. International Socity on Thrombosis and Hemostasis, ISTH 2019, Melbourne, july 6-10, Australia

[277] Shah Shahid, Aldybiat Iman, Ullah Matti, Kaci Rachid, Eveno Clarisse, Pocard Marc, Mirshahi Massoud. Fibrin deposit on the peritoneal surface serve as a niche for cancer expansion in carcinomatosis patients. International Socity on Thrombosis and Hemostasis, ISTH 2019, Melbourne, july 6-10, Australia

[278] Al-dybiat I, Shah S, Ullah M, Bellalou M, Abdelhamid D, Mirshahi S, Soria J, Pocard M, Mirshahi M. Cancer cell implantation fibrin deposition on the cicatrices zones on peritoneal injuries, 1er congress of ISSPP, international Society for the study of pleura and peritoneum. Singapor 2019

[279] Ullah M, Azzazen D, Aldybiat I, Kaci R, Pocard M, Mirshahi M. Immune suppressor proteins HLA-G and PDL-1 in peritoneal carcinomatosis. 1er congress of ISSPP, international Society for the study of pleura and peritoneum. Singapor 2019

[280] Shahid Shah, Shahsoltan Mirshahi, Geneviève Contant, Cynthia Pimpie, Rea Lo Dico, Jeannette Soria, Marc Pocard, Massoud Mirshahi. Heparanase via an autocrine secretion is involved in acquisition of mesenchymal phenotype and tumor cell malignancy in gastric signet-ring cell adenocarcinoma. 1er congress of ISSPP, international Society for the study of pleura and peritoneum. Singapor 2019

[281] Al-dybiat I, Shah S, Ullah M, Bellalou M, Abdelhamid D, Mirshahi S, Soria J, Pocard M, Mirshahi M., Injured peritoneum enhances cancer cell implantation through the deposited fibrin on the cicatrices zones, Peritoneal carcinomatosis ISSPP: 5 workshop on Basic Science PARIS the 27 September 2019

[282] Ullah M., Azazzen D, Al-dybiat I, Kaci R, Pocard M., Mirshahi M. Check point and immune interaction regarding peritoneal metastasis growing. Peritoneal carcinomatosis ISSPP: 5 workshop on Basic science , PARIS the 27 September 2019

[283] Aldybiat I, Shah S, Ullah M, Bellalou M, Mirshahi S, Soria J, Pocard M, Mirshahi M. Tissue Wound favors cancer cell implantation via fibrin deposit on the cicatrices zones Satellite meeting of Internantional Society of Precision cancer Medecine, 2019, Yeosu, Korea

[284] Shah S, Mirshahi S, Contant G, Pimpie C, Lo Dico R, Soria J, Pocard M, Mirshahi M.

Heparanase induces epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma, International Gastric Cancer Congress IGCC 2019 Congress, 2019, Prage, Czech Republic.

[285] Mirshahi M., Identification of an adherent cell that interact with leukemic cells and induced chemo resistance. The European Congress on Leukemias - Between Cutting Edge and Grey Zone (Leukemia2019) , Vienne, Autriche.

[286] Rémi Varin, Laurent Garderet, Nadia Benabbou, Jean Pierre Marie, Marc. Pocard, Massoud. Mirshahi . Isolation of cells from adherent bone marrow mononuclear cells that favored malignant hematopoietic and solid tumor cell adhesion in vitro. The European Congress on Leukemias - Between Cutting Edge and Grey Zone (Leukemia2019) , Vienne, Autriche

[287] Iman Al dybiat , Massoud. Mirshahi, Damaged tissues promote the implantation of cancer cells through deposits of fibrin on scarred areas , International Symposium on Innoative development of science, Dushanbe Tajikistan ,10 Dec. 2020,

[288] AL Dybiat I, Arefi-Khonsari F & Massoud Mirshahi , Biodegradable nano film generated by plasma stream, A new window for cancer therapy , International Symposium on Innoative development of science, Dushanbe Tajikistan, 10 Dec. 2020 .

[289] Matti Ullah, Massoud Mirshahi Cancer cells during their division resist the immune system via the secretion of HLA-G and PDL-1, International Symposium on Innoative development of science, Dushanbe Tajikistan, 10 Dec. 2020.

[290] Massoud. Mirshahi, Soluble HLA-G and PD-L1 down regulate Cancer attack process in cell mitosis, ISPCM, Seoul, Korea 28 Dec. 2020.


THESES, MEMOIRES


  • Mémoire pour l'obtention du CES de Cancérologie Générale et Expérimentale, 1982.

Mirshahi M. Hybridation cellulaire et production d'anticorps monoclonaux dirigés contre la leucémie aiguë lymphoblastique humaine.

  • Thèse Doct. Médecine, et Ph. D, Université de Limburg, Hollande, 1984

Mirshahi, M. Contribution à l'étude du fibrinogène, de la fibrinoformation et de la fibrinolyse par l'utilisation d'anticorps monoclonaux.

  • Thèse Doct. Etat, Science de Biologie Humaine, Université Paris VII, 1986.

Mirshahi M. L'auto-antigène S, protéine spécifique des photorécepteurs et de l'épiphyse. Etude immunohistochimique, immunopathologique et fonctionnelle.

  • D.E.R.B.H. en Hématologie, mention physiologie et biochimie de l'hémostase, Université Paris VII, 1987.

Mirshahi M. Anticorps monoclonaux contre le fibrinogène, et ses produits de dégradation.


VALORISATION


Licences des productions scientifiques :

  1. Les anticorps monoclonaux contre les antigènes leucémiques, INSERM, Immunotech.

  2. Les anticorps monoclonaux contre des produits de dégradation de la fibrine/fibrinogène, INSERM, Immunotech.

  3. Les anticorps monoclonaux contre de l’arrestine, Université Paris VI, Abcys.

Dépôt de brevets :

1- Somonola, principe actif d’origine vegetale, activites (anti-oxydant et anti-inflammatoire (hepatoprotecteur) n° tj 366, application, 02000759, tadjikistan, 26 09 2002, valide : 26 9 2022.

2- The fertilized eggs of the indian horseshoe crab (tachypleus gigas, muller) promotes vasculogenesis (application no 0221nf2005, 6/20/2005)

3- The fertilized eggs of the indian horseshoe crab (tachyplieus gigas,

muller) helps in maintaining the original phenotype of cd 34+ stem cells and enhances colony formation in vitro (application no: 0222nf2005, 6/20/2005)

  1. "hospicells" (n/ref x04032; v/ref bio 03262 m. mirshahi).Universite Paris VI, 2007

Extention, 2009 par l’université Paris VI et deux soutenance de thèse à l’Université Paris XI.

des cellules du micro-environnement non encore décrites dans la littérature que nous avons appelées « hospicells » et dont le rôle apparaît très important dans la chimiorésistance, l’immunorégulation et la maladie résiduelle en cancérologie

(N° PCT/FR2008/051188, extension international du brevet, UPMC, N°X07013-Mirshahi).

  1. Gepatoplolis, eurasia/tajikistan, 02.1/014 ; 08.08.2007.

des dérivés médicamenteux issus de produits naturels. M2Yn,. Nous avons montré, en collaboration avec l’Académie des Sciences du Tadjikistan, que ce produit bloquait l’angiogenèse dans les cancers (un brevet sur ce produit a été déposé au Tadjikistan (Eurasia/Tajikistan, 02.1/014 ; 08.08.2007)

  1. Endothelial protein C receptor in cancer, Université Paris VI, 30 juillet 2009, fr 09/55347, Extention 2010. [PCT/FR2010/051631 concernant l'invention « Méthode de diagnostic d'un cancer et de détermination de la sévérité d'un cancer chez un individu »] par l’université Paris VI et d’une soutenance de thèse à l’Université Paris XI.

  1. Method for producing a biodegradable fiber material containing a drug using electrospinning, WO2016159240A1 2016 006, INSERM Transfert paris France